[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 4639
1. Kampschreur LM, Hoogeveen EK, Op den Akker JW, Beutler JJ, Beems T, Dorresteijn LDA, de Sévaux RGL: A haemodialysis patient with back pain: brown tumour as a cause of spinal cord compression under cinacalcet therapy. NDT Plus; 2010 Jun;3(3):291-295

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A haemodialysis patient with back pain: brown tumour as a cause of spinal cord compression under cinacalcet therapy.
  • Magnetic resonance imaging showed a tumour that severely compressed the myelum of the thoracic spine.
  • Histological investigation revealed a brown tumour or osteoclastoma, an erosive bony lesion caused by increased osteoclastic activity and peritrabecular fibrosis.
  • A brown tumour is a benign tumour that is a rare complication of severe renal hyperparathyroidism.
  • The brown tumour developed despite a 1-year treatment of the patient with cinacalcet, which, however, did not result in a major decrease in serum iPTH concentration (from 110 to 69 pmol/L: 37% reduction).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] NDT Plus. 2008 Aug;1(Suppl 3):iii9-iii13 [25983977.001]
  • [Cites] Eur J Radiol. 1992 Jan-Feb;14 (1):67-71 [1563408.001]
  • [Cites] Endocr J. 2009;56(2):263-8 [19122347.001]
  • [Cites] NDT Plus. 2008 Aug;1(Suppl 3):iii2-iii8 [25983967.001]
  • [Cites] Rheumatol Int. 2007 Nov;28(1):77-81 [17569048.001]
  • [Cites] Am J Kidney Dis. 2008 Sep;52(3):A37-9 [18725008.001]
  • [Cites] Neuroradiology. 1990;32(4):343 [2234400.001]
  • [Cites] J Orthop Surg (Hong Kong). 2009 Apr;17 (1):90-5 [19398802.001]
  • [Cites] Radiographics. 1993 Mar;13(2):357-79 [8460225.001]
  • [Cites] Spine (Phila Pa 1976). 1993 Jun 1;18(7):936-7 [8316899.001]
  • [Cites] Clin Nephrol. 2001 May;55(5):419-23 [11393391.001]
  • [Cites] Joint Bone Spine. 2000;67(3):230-3 [10875324.001]
  • [Cites] Joint Bone Spine. 2006 Dec;73(6):748-50 [16650789.001]
  • [Cites] Semin Dial. 2007 Jul-Aug;20(4):309-15 [17635820.001]
  • [Cites] Scand J Urol Nephrol. 1978;12(2):185-7 [694445.001]
  • [Cites] Eur J Radiol. 2003 May;46(2):85-95 [12714225.001]
  • [Cites] J Neurosurg. 1999 Apr;90(2 Suppl):242-6 [10199256.001]
  • [Cites] NDT Plus. 2010 Feb;3(1):71-3 [25949410.001]
  • [Cites] Spine (Phila Pa 1976). 2004 Jun 15;29(12 ):E251-5 [15187649.001]
  • [Cites] Am J Med. 1986 Sep;81(3):545-7 [3752152.001]
  • (PMID = 28657067.001).
  • [ISSN] 1753-0784
  • [Journal-full-title] NDT plus
  • [ISO-abbreviation] NDT Plus
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; brown tumour / hyperparathyroidism / osteoclastoma / spine
  •  go-up   go-down


2. Bestard Matamoros O, Poveda Monje R, Ibernon Vilaró M, Carrera Plans M, Grinyó Boira JM: [Systemic AA amyloidosis induced by benign neoplasms]. Nefrologia; 2008;28(1):93-8
MedlinePlus Health Information. consumer health - Amyloidosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Systemic AA amyloidosis induced by benign neoplasms].
  • [Transliterated title] Amiloidosis secundaria (AA) asociada a tumoraciones benignas.
  • Amyloidosis is a systemic disorder characterized by the extracellular tissue deposition of insoluble, toxic aggregates in bundles of beta-sheet fibrillar proteins.
  • It has been described at least 25 different human protein precursors of amyloid fibrils, which will describe its corresponding amyloid disease.
  • The later (AA), is caused by deposition of fibrils composed of fragments of the acute phase reactant serum amyloid A (SAA) and complicates chronic diseases with ongoing or recurring inflammation, namely; rheumatoid arthritis (RA), juvenile chronic polyarthritis, ankylosing spondylitis, familial periodic fever syndromes (Familial Mediterranean Fever), chronic infections and furthermore, some neoplasms (mainly renal cell carcinoma and Hodgkin's disease).
  • Despite its less frequent association, some benign neoplasms can subsequently complicate to AA amyloidosis, therefore, an early diagnose and successful treatment may lead indeed, to regression of the amyloid disease.
  • Herein, we present two cases of AA amyloidosis, both of them caused by 2 different benign neoplasms: 1.
  • Further investigation lead to the finding of a hialyne-vascular type Castleman's disease located in the retroperitoneum (fig. 2).
  • Although other chronic inflammatory diseases complicate more frequently to AA amyloidosis, benign tumors have to be taken into account as a potential ethiological cause for secondary amyloidosis.
  • [MeSH-major] Amyloidosis / etiology. Neoplasms / complications

  • Genetic Alliance. consumer health - Amyloidosis.
  • Genetic Alliance. consumer health - Amyloidosis AA.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18336138.001).
  • [ISSN] 0211-6995
  • [Journal-full-title] Nefrología : publicación oficial de la Sociedad Española Nefrologia
  • [ISO-abbreviation] Nefrologia
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


3. Liu J, Zheng S, Yu JK, Zhang JM, Chen Z: Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor. J Zhejiang Univ Sci B; 2005 Jan;6(1):4-10
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
  • To screen and evaluate protein biomarkers for the detection of gliomas (Astrocytoma grade I-IV) from healthy individuals and gliomas from brain benign tumors by using surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) coupled with an artificial neural network (ANN) algorithm.
  • SELDI-TOF-MS protein fingerprinting of serum from 105 brain tumor patients and healthy individuals, included 28 patients with glioma (Astrocytoma I-IV), 37 patients with brain benign tumor, and 40 age-matched healthy individuals.
  • An accuracy of 95.7%, sensitivity of 88.9%, specificity of 100%, positive predictive value of 90% and negative predictive value of 100% were obtained in a blinded test set comparing gliomas patients with healthy individuals; an accuracy of 86.4%, sensitivity of 88.9%, specificity of 84.6%, positive predictive value of 90% and negative predictive value of 85.7% were obtained when patient's gliomas was compared with benign brain tumor.
  • The high sensitivity and specificity achieved by the use of selected biomarkers showed great potential application for the discrimination of gliomas patients from healthy individuals and gliomas from brain benign tumors.
  • [MeSH-major] Astrocytoma / blood. Astrocytoma / diagnosis. Biomarkers, Tumor / blood. Brain Neoplasms / blood. Brain Neoplasms / diagnosis. Diagnosis, Computer-Assisted / methods. Neoplasm Proteins / blood. Peptide Mapping / methods

  • Genetic Alliance. consumer health - Glioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] CA Cancer J Clin. 2003 Jan-Feb;53(1):5-26 [12568441.001]
  • [Cites] Pain. 2003 Apr;102(3):251-6 [12670666.001]
  • [Cites] Curr Med Chem. 2003 May;10(10):831-43 [12678686.001]
  • [Cites] J Clin Oncol. 2003 May 15;21(10 Suppl):200s-205s [12743135.001]
  • [Cites] Lung Cancer. 2003 Jun;40(3):267-79 [12781425.001]
  • [Cites] Curr Pharm Biotechnol. 2004 Feb;5(1):45-67 [14965209.001]
  • [Cites] Curr Opin Biotechnol. 2004 Feb;15(1):24-30 [15102462.001]
  • [Cites] Electrophoresis. 2000 Apr;21(6):1164-77 [10786889.001]
  • [Cites] N Engl J Med. 2001 Jan 11;344(2):114-23 [11150363.001]
  • [Cites] Bioinformatics. 2002 Mar;18(3):395-404 [11934738.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1160-9 [12142368.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1296-304 [12142387.001]
  • [Cites] Clin Cancer Res. 2002 Aug;8(8):2541-52 [12171882.001]
  • (PMID = 15593384.001).
  • [ISSN] 1673-1581
  • [Journal-full-title] Journal of Zhejiang University. Science. B
  • [ISO-abbreviation] J Zhejiang Univ Sci B
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Controlled Clinical Trial; Letter; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  • [Other-IDs] NLM/ PMC1390751
  •  go-up   go-down


Advertisement
4. Kawata R, Lee K, Araki M, Takenaka H: Safety and usefulness of an electric knife during surgery for parotid benign tumor: postoperative facial paresis and its risk factors. Acta Otolaryngol; 2007 Sep;127(9):966-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Safety and usefulness of an electric knife during surgery for parotid benign tumor: postoperative facial paresis and its risk factors.
  • PATIENTS AND METHODS: In this study, the safety and usefulness of an electric knife in parotid surgery were confirmed by evaluating patients with parotid benign tumor who underwent surgery using an electric knife.
  • The subjects were 135 patients with parotid benign tumors.
  • Depending on the tumor site, transient paresis was observed in 8 of the 13 patients with tumors in the deep lobe but in 28 (22.9%) of the 122 patients with tumors in the superficial lobe.
  • [MeSH-major] Electrocoagulation / methods. Facial Paralysis / prevention & control. Parotid Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17712677.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


5. González-Tortosa J, Ferri-Níguez B, Ros de San Pedro J: [Cerebellopontine angle meningeal melanocytoma: a benign tumor?]. Neurocirugia (Astur); 2009 Aug;20(4):372-9; discussion 379-80
Hazardous Substances Data Bank. Fotemustine .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cerebellopontine angle meningeal melanocytoma: a benign tumor?].
  • [Transliterated title] Melanocitoma meníngeo del ángulo pontocerebeloso: un tumor benigno?
  • We report a case of a rare meningeal melanocytoma in the cerebellopontine angle.
  • One year after tumor gross total removal, the patient suffered a sudden and devastating meningeal melanomatosis.
  • The relevant literature is reviewed looking for the keys to establish preoperative diagnosis and to obtain information about its treatment and postsurgical management.
  • [MeSH-major] Cerebellar Neoplasms / pathology. Cerebellopontine Angle / pathology. Melanocytes / pathology. Meningeal Neoplasms / pathology. Nevus / pathology
  • [MeSH-minor] Antineoplastic Agents, Alkylating / therapeutic use. Diagnosis, Differential. Disease Progression. Fatal Outcome. Gait Disorders, Neurologic / etiology. Hearing Loss, Sensorineural / etiology. Humans. Magnetic Resonance Imaging. Male. Melanoma / diagnosis. Melanoma / pathology. Middle Aged. Neoplasm Invasiveness. Neoplasm Recurrence, Local / drug therapy. Neoplasm Recurrence, Local / pathology. Neurilemmoma / diagnosis. Nitrosourea Compounds / therapeutic use. Organophosphorus Compounds / therapeutic use

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Moles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19688139.001).
  • [ISSN] 1130-1473
  • [Journal-full-title] Neurocirugía (Asturias, Spain)
  • [ISO-abbreviation] Neurocirugia (Astur)
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Nitrosourea Compounds; 0 / Organophosphorus Compounds; GQ7JL9P5I2 / fotemustine
  • [Number-of-references] 44
  •  go-up   go-down


6. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP: [Human kallikrein 13 expression in salivary gland tumors]. Int J Biol Markers; 2006 Apr-Jun;21(2):106-110

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Human kallikrein 13 expression in salivary gland tumors].
  • The aim of this study was to determine whether hK13 is expressed in salivary gland tissues and salivary gland tumors (both benign and malignant), in order to compare normal with tumor tissues.
  • The results of this study indicate that most salivary gland tumors show high levels of expression of hK13.
  • Ductal cells and cells lining duct-like structures showed a higher intensity of staining than non-ductal cells in most tumors.
  • Tumors which exhibited only non-ductal cells also exhibited cytoplasmic staining.
  • In conclusion, we demonstrate the high expression of hK13 in several common salivary gland tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28207129.001).
  • [ISSN] 1724-6008
  • [Journal-full-title] The International journal of biological markers
  • [ISO-abbreviation] Int. J. Biol. Markers
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


7. Choi JC, Yu CM, Ryu YJ, Jeon K, Choi KA, Kwon OJ, Kim H: The role of endoscopic surgery for completely obstructive endobronchial benign tumor. Korean J Intern Med; 2006 Mar;21(1):15-9
MedlinePlus Health Information. consumer health - Endoscopy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of endoscopic surgery for completely obstructive endobronchial benign tumor.
  • BACKGROUND: The improving techniques of therapeutic bronchoscopy have been replacing conventional surgery for resecting endobronchial benign tumor.
  • To evaluate the role of endoscopic surgery for completely obstructive endobronchial benign tumor, we retrospectively reviewed the medical records of 7 patients who underwent bronchoscopic resection due to completely obstructive benign tumor.
  • After the stalk of tumor was identified with using a 1 mm biopsy forceps as a probe, a Nd-YAG laser was used to coagulate the stalk of tumor.
  • The tumor was then removed.
  • CONCLUSIONS: Endoscopic surgery could be applied to the patients with completely obstructive endobronchial benign tumor.
  • [MeSH-major] Bronchial Neoplasms / surgery. Endoscopy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Chest. 2002 Jul;122(1):202-5 [12114359.001]
  • [Cites] J Thorac Cardiovasc Surg. 2001 Jan;121(1):180-2 [11135176.001]
  • [Cites] Ann Thorac Surg. 2003 Apr;75(4):1300-2 [12683579.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2003 Apr;260(4):219-22 [12709807.001]
  • [Cites] Curr Opin Pulm Med. 2003 Jul;9(4):301-8 [12806244.001]
  • [Cites] Otolaryngol Pol. 2004;58(1):187-90 [15101279.001]
  • [Cites] Tuberk Toraks. 2004;52(3):272-4 [15351942.001]
  • [Cites] J Thorac Cardiovasc Surg. 1970 Oct;60(4):589-99 [5511893.001]
  • [Cites] Thorax. 1981 Mar;36(3):175-8 [7197061.001]
  • [Cites] Thorax. 1982 Sep;37(9):688-92 [7157223.001]
  • [Cites] Chest. 1988 Jul;94(1):15-21 [3383627.001]
  • [Cites] Eur Respir J. 1989 May;2(5):479-80 [2759225.001]
  • [Cites] Scott Med J. 1992 Oct;37(5):141-3 [1492204.001]
  • [Cites] Eur J Cardiothorac Surg. 1993;7(8):445-6 [8398195.001]
  • [Cites] South Med J. 1993 Oct;86(10):1164-5 [8211338.001]
  • [Cites] Surg Today. 1995;25(2):161-3 [7772920.001]
  • [Cites] Chest. 1995 Jun;107(6):1744-51 [7781378.001]
  • [Cites] Surg Today. 1995;25(12):1057-60 [8645942.001]
  • [Cites] Clin Chest Med. 1999 Mar;20(1):107-22 [10205721.001]
  • [Cites] Chest. 2003 Jan;123(1):293-6 [12527636.001]
  • (PMID = 16646559.001).
  • [ISSN] 1226-3303
  • [Journal-full-title] The Korean journal of internal medicine
  • [ISO-abbreviation] Korean J. Intern. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC3891058
  •  go-up   go-down


8. Gloria C, Li Q, Xu L, Zhang W: Differentiation of diffusion coefficients to distinguish malignant and benign tumor. J Xray Sci Technol; 2010;18(3):235-49
Hazardous Substances Data Bank. Water .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differentiation of diffusion coefficients to distinguish malignant and benign tumor.
  • Taking advantage of Diffusion Weighted Imaging (DWI) to characterize the random movement of water molecules in biological tissue, this article intends to review the Intravoxel Incoherent Motion (IVIM) theory as a valuable method to find the differentiation between malignant and benign tumor based on the microcirculation of blood in the capillaries.
  • IVIM is measured by means of a parameter called apparent diffusion coefficient (ADC).
  • Through the application of IVIM to the imaging processing software, it will be possible to set up an expert system with screening, discrimination, staging and therapeutic evaluation function of tumor.
  • [MeSH-major] Diffusion Magnetic Resonance Imaging / methods. Image Processing, Computer-Assisted / methods. Models, Theoretical. Neoplasms. Software
  • [MeSH-minor] Aged. Diagnosis, Differential. Diffusion. Female. Humans. Liver Neoplasms / pathology. Microcirculation / physiology. Perfusion. Water

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20714083.001).
  • [ISSN] 1095-9114
  • [Journal-full-title] Journal of X-ray science and technology
  • [ISO-abbreviation] J Xray Sci Technol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 059QF0KO0R / Water
  •  go-up   go-down


9. Zhang H, Feng Y, Jiang L: [Tumorectomy by trans-oral approach of macrosis benign neoplasms in parapharyngeal space (reports of 6 cases)]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun;24(12):556-8
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Tumorectomy by trans-oral approach of macrosis benign neoplasms in parapharyngeal space (reports of 6 cases)].
  • OBJECTIVE: To discuss the feasibility of tumorectomy by transoral approach of macrosis benign neoplasms in parapharyngeal space.
  • METHOD: Retrospective analyze 6 patients of macrosis benign neoplasms in parapharyngeal space from January 2005 to May 2008, and all neoplasms were removed by transoral approach.
  • RESULT: The neoplasms were all removed completely and successfully, and postoperative recovery were good and no complications were found.
  • CONCLUSION: Preoperative imaging examination is very important for diagnosis and treatment of benign neoplasm in parapharyngeal space, which is especially helpful to understand the scope of the tumor, and the relationship with carotid artery and vein.
  • On this basis, it is feasible to select the appropriate cases to resect huge benign neoplasm in parapharyngeal space.
  • [MeSH-major] Neoplasms / surgery. Oropharynx / surgery. Otorhinolaryngologic Surgical Procedures / methods. Pharyngeal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20806862.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


10. Grobmyer SR, Stasik CN, Draganov P, Hemming AW, Dixon LR, Vogel SB, Hochwald SN: Contemporary results with ampullectomy for 29 "benign" neoplasms of the ampulla. J Am Coll Surg; 2008 Mar;206(3):466-71
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contemporary results with ampullectomy for 29 "benign" neoplasms of the ampulla.
  • STUDY DESIGN: We retrospectively reviewed our experience with ampullectomy in 29 patients with a preoperative benign histologic diagnosis over 15 years (1991 to 2006).
  • Ampullary adenomatous neoplasms were present in 89% of patients.
  • After ampullectomy (median followup=16 months), recurrences were identified in two patients (8%) with benign tumors.
  • [MeSH-major] Adenoma / surgery. Ampulla of Vater. Carcinoma / surgery. Common Bile Duct Neoplasms / pathology. Common Bile Duct Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cohort Studies. Humans. Middle Aged. Neoplasm Invasiveness. Predictive Value of Tests. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18308217.001).
  • [ISSN] 1879-1190
  • [Journal-full-title] Journal of the American College of Surgeons
  • [ISO-abbreviation] J. Am. Coll. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Nguyen NT, Reavis KM, El-Badawi K, Hinojosa MW, Smith BR: Minimally invasive surgical enucleation or esophagogastrectomy for benign tumor of the esophagus. Surg Innov; 2008 Jun;15(2):120-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minimally invasive surgical enucleation or esophagogastrectomy for benign tumor of the esophagus.
  • Experience in surgical resection of benign tumor of the esophagus is limited.
  • Authors performed a chart review of 5 patients who underwent minimally invasive surgical resection of benign esophageal tumor.
  • Main outcome measures included operative approaches, tumor's location and size, and outcomes.
  • Tumor location were middle esophagus (n = 1), distal esophagus (n = 2), and gastroesophageal junction (n = 2).
  • Surgical pathology showed leiomyoma in 3 patients and gastrointestinal stromal tumor in 2 patients.
  • Tumor size ranged from 1.1 to 10.5 cm.
  • There has been no tumor recurrence at a mean follow-up of 14 months.
  • Minimally invasive surgical enucleation or esophagogastrectomy for benign esophageal tumor is feasible and safe.
  • The optimal approaches should be tailored based on the location and size of the tumor.
  • [MeSH-major] Esophageal Neoplasms / surgery. Esophagectomy / methods. Gastrectomy / methods. Minimally Invasive Surgical Procedures

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18492731.001).
  • [ISSN] 1553-3506
  • [Journal-full-title] Surgical innovation
  • [ISO-abbreviation] Surg Innov
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Noonan AM, Carney DN, McCaffrey J: Review of neoplastic brachial plexopathy at the Mater Misericordiae University Hospital, Ireland. J Clin Oncol; 2009 May 20;27(15_suppl):e20681

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Review of neoplastic brachial plexopathy at the Mater Misericordiae University Hospital, Ireland.
  • : e20681 Background: Neoplastic brachial plexopathy (NBP) may occur with benign or malignant neoplasms.
  • 18 MRIs were performed in patients with a known cancer diagnosis, 1 was performed in a patient with a benign thymoma, 1 with a neurofibroma and the remaining 17 MRIs were ordered for other conditions.
  • Of the 20 MRIs performed (18 in patients with cancer, 2 in patients with a history of benign neoplasms), 6 (30%) confirmed a diagnosis of NBP.
  • 27.8% (5/18) of patients with a diagnosis of cancer had NBP (3 had metastatic breast cancer, 2 had non-small cell lung cancer (NSCLC).
  • Median age at diagnosis was 67 years (range 35 to 86 years).
  • Radiotherapy was the treatment of choice for 5 patients with cancer diagnosis, followed by chemotherapy also for one patient.
  • CONCLUSIONS: In our series in the past 5 years, 9% (6/66) of total number of MRIs of brachial plexus performed were positive for a diagnosis of NBP.
  • NBP is devastating diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961791.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Camargo VP, Maki RG: Clinical outcomes of systemic therapy for patients with desmoids. J Clin Oncol; 2009 May 20;27(15_suppl):10585

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 10585 Background: Desmoids are rare, slow growing, histologically benign tumors without metastatic potential.
  • METHODS: We examined outcomes of patients with desmoid tumors receiving systemic therapy at a single institution, to provide a basis for examination of newer agents.
  • Retrospective chart review of 682 patients with desmoid tumors (1982-2006) from a prospectively collected sarcoma database.
  • Patients without measurable disease, those receiving therapy we could not document, and those receiving prophylactic therapy were excluded.
  • Nine patients died, 7 of progressive disease/surgical complications, and two with Gardner syndrome-related malignancies.
  • Five partial responses were observed with anthracyclines (43 courses administered), 2 with hormonal therapy (32 courses), and 1 with imatinib (35 courses), for 8 PR s.
  • CONCLUSIONS: Anthracycline-containing regimens, hormonal therapy, and tyrosine kinase inhibitors have modest activity against desmoid tumors.
  • The choice of therapy for these morbid and potentially fatal tumors should balance the efficacy of treatments with their short- and long-term side effects.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963883.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Ruiz-Garcia EB, Scott V, Machavoine C, Bidart JM, Lacroix L, Delaloge S, Andre F: Use of gene expression profiling to identify fibronectin 1 and MIG as candidate biomarkers for breast cancer screening. J Clin Oncol; 2009 May 20;27(15_suppl):e22034

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We used differential gene expression between breast cancer samples and benign tumors to identify candidate biomarkers for blood-based screening Methods: 3 candidate proteins (Fibronectin 1, CXCL9, Complement Factor B) were identified from a gene expression dataset that included 120 breast cancer samples and 45 benign lesions.
  • Proteins selection was done with these criteria: differential gene expression between cancer and benign lesion, protein released in the extracellular medium (SwissProt), commercially available ELISAkit, accuracy of the ELISA assay in a feasibility study (n=23).
  • RESULTS: 73% of the patients were cT1-T2 tumour.
  • AUC for breast cancer diagnosis were 0.78 and 0.62 for Fibronectin 1 and CXCL9 respectively.
  • Similar performances were observed for ER-negative tumors Conclusions: This study suggests that Fibronectin 1/CXCL9 dosage in serum could screen a significant rate of breast cancer, including ER-negative breast cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963150.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Norden AD, Raizer JJ, Lamborn KR, Abrey LE, Chang SM, Gilbert MR, Cloughesy TF, Prados MD, Lieberman F, Wen P: Phase II trials of erlotinib or gefitinib in patients with recurrent meningiomas. J Clin Oncol; 2009 May 20;27(15_suppl):2062

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The epidermal growth factor receptor (EGFR) is often over-expressed in meningiomas and may promote tumor growth.
  • METHODS: Patients with recurrent histologically confirmed meningiomas and no more than two previous chemotherapy regimens were treated with gefitinib 500 mg/day or erlotinib 150 mg/day until tumor progression or unacceptable toxicity.
  • Eight patients (32%) had benign tumors, 9 (36%) atypical, and eight (32%) malignant.
  • For benign tumors, the 6-month progression-free survival (PFS6) was 29%, 12-month PFS (PFS12) 0%, 6-month overall survival (OS6) 63%, and 12-month OS (OS12) 50%.
  • For atypical/malignant tumors, PFS6 was 25%, PFS12 19%, OS6 81%, and OS12 68%.
  • Of 21 evaluable patients, there were no responses; eight patients (38%) had stable disease, and 13 (62%) had progressive disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964693.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Aharinejad S, Thomas A, Singer C, Kubista E, Paulus P, Miksovsky A, Abraham D: Significance of serum colony-stimulating factor-1 as a breast cancer marker. J Clin Oncol; 2009 May 20;27(15_suppl):11071

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: In a prospective study in 799 women with no history of malignant disease undergoing surgery, serum CSF-1 levels were measured by a commercially available ELISA.
  • In this cohort, 312 patients had breast cancer and 487 age-matched women had benign tumors.
  • The tumor size, nodal and metastasis status, histological tumor type, hormone and human epidermal growth factor receptor 2 (HER2) and menopausal status were evaluated.
  • Mean CSF-1 serum concentrations were compared between the patient groups by non-parametric Wilcoxon two-sample and Kruskal-Wallis test.
  • RESULTS: Mean serum CSF-1 concentrations were significantly higher in all patients with malignant tumors (502±429 pg/mL) as compared to those with benign tumors (382±344 pg/mL) (p<0.0001, Wilcoxon).
  • Increased CSF-1 concentrations were significantly related to malignant versus non-malignant disease in logistic regression and receiver operating characteristic analysis (p<0.0001, AUC=0.6).
  • Increased CSF-1 levels in patients with malignant tumors were associated with postmenopausal (p=0.0038) but not premenopausal (p=0.94) status (Wilcoxon).
  • Serum CSF-1 concentrations did not correlate significantly with tumor size, nodal and metastasis status, hormone receptor and HER2 status of patients (Kruskal-Wallis).
  • While its serum levels are not related to breast cancer stage at diagnosis, they might be useful for breast cancer screening in postmenopausal women.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963190.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Mergenthaler U, Heymanns J, Köppler H, Thomalla J, van Roye C, Weide R: Evaluation of psycho-social distress in patients treated in a community-based oncology group practice in Germany. J Clin Oncol; 2009 May 20;27(15_suppl):e20577

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients were classified into the disease groups solid tumors, hematological neoplasms, benign hematological diseases and other non-malignant diseases.
  • Patients with other non-malignant diseases (81% autoimmune diseases or hereditary hemochromatosis) showed the highest average distress level of 5.2.
  • Regarding the treatment phases, the most distressed patients were patients who just learned about their diagnosis of relapsed or metastatic disease (6.4), patients receiving Best Supportive Care (5.4) and patients receiving adjuvant anti-hormonal therapy (5.4).
  • CONCLUSIONS: The study shows that cancer patients do not necessarily show higher distress than patients with severe non-malignant diseases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961101.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Takehara K, Miyamoto K, Kawakami Y, Kumagai M, Samura O, Egawa M, Nakamura H, Mizunoe T, Taniyama K, Saji F: Epigenetic alteration of BRCA1 in human ovarian tumors. J Clin Oncol; 2009 May 20;27(15_suppl):e16532

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epigenetic alteration of BRCA1 in human ovarian tumors.
  • The epigenetic alteration of BRCA1 and its contribution in sporadic ovarian tumors are not fully understood.
  • METHODS: We evaluated the DNA methylation status of the BRCA1 5' CpG island by methylation-specific PCR in 12 human ovarian cancer cell lines and 39 primary epithelial ovarian tumor specimens.
  • Cases included the following: malignant (n = 16), borderline (n = 8), and benign (n = 16) tumors.
  • RESULTS: BRCA1 was hypermethylated in one of 12 (8%) ovarian cancer cell lines and 15 of 39 (38%) primary ovarian tumors.
  • Relative to clinicopathological features, BRCA1 methylation was detected in 39% of malignant and borderline tumors and in 38% of benign tumors, suggesting the importance of BRCA1 pathway in both types of tumors.
  • CONCLUSIONS: BRCA1 was found to be frequently hypermethylated both in benign and malignant ovarian tumors.
  • Our results suggest that epigenetic alteration of BRCA1 might play a role in the development of benign and malignant sporadic ovarian tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27960779.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Gundrum JD, Go R, Kwong R: Cancer in the oldest old population in the United States: Current statistics and projections. J Clin Oncol; 2009 May 20;27(15_suppl):9553

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We included patients who had a previous cancer before age 85, but excluded benign tumors, myeloproliferative, and myelodysplastic neoplasms.
  • The 10 leading cancers by incidence (both sexes and decreasing order) are colorectal (388.9), lung (287.7), breast (250), prostate (211.5), urinary bladder (162.5), non-Hodgkin lymphoma (110.9), leukemia (85.1), melanoma (65), renal (46.4), and uterine (40.2).
  • The incidences of melanoma, non-Hodgkin lymphoma, renal, and lung cancers are increasing, while those of leukemia, prostate, breast, and colorectal cancers are decreasing.
  • Cancer specific survival (CSS) has been increasing continuously since 1973 for melanoma, non-Hodgkin lymphoma, breast, colorectal, prostate, and urinary bladder cancers but decreasing in recent years for colorectal, breast, prostate, and uterine cancers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963637.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Chen WL, Yang ZH, Huang ZQ, Chai Q, Zhang DM: Facial contour reconstruction after benign tumor ablation using reverse facial-submental artery deepithelialized submental island flaps. J Craniofac Surg; 2010 Jan;21(1):83-6
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Facial contour reconstruction after benign tumor ablation using reverse facial-submental artery deepithelialized submental island flaps.
  • Reverse facial-submental artery deepithelialized submental island flaps were used for reconstructing facial contour deformities in 5 patients after benign tumor ablation.
  • Proper aesthetics and complete functionality were achieved, and no donor-site problems occurred.
  • The flap can be used reliably for facial contour reconstruction of middle and upper facial contour deformities after benign tumor ablation in the cheek and inferior temple.
  • [MeSH-major] Carcinoma, Basal Cell / surgery. Facial Neoplasms / surgery. Reconstructive Surgical Procedures / methods. Surgical Flaps / blood supply
  • [MeSH-minor] Adult. Cheek. Female. Forehead. Humans. Male. Neoplasm Recurrence, Local / surgery. Postoperative Complications. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20061969.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Zhu D, Sun Y, Yao P, Zheng J, Yang Z: [Experience in treating anterior-lateral benign tumor in middle cranial fossa base through standard facial translocation approach ]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Apr;21(7):304-5, 308

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Experience in treating anterior-lateral benign tumor in middle cranial fossa base through standard facial translocation approach ].
  • OBJECTIVE: To observe the feasibility and effect of improved standard facial translocation approach in treating anterior-lateral benign tumor in middle cranial fossa base.
  • METHOD: We excised 10 cases of benign tumor originating from pharynx nasals of pterygopalatine fossa and expanding toward the cavernous sinus of middle cranial fossa, infratemporal fossa or pterygo-maxillary space.
  • CONCLUSION: Reforming facial translocation approach in treating anterior-lateral benign tumor in middle cranial fossa base was safe and obtained ideal curative effect in near future.
  • [MeSH-major] Cranial Fossa, Middle / surgery. Craniotomy / methods. Skull Base Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17580715.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


22. Sen S, Senturk E, Kuman NK, Pabuscu E, Kacar F: PEComa (clear cell "sugar" tumor) of the lung: a benign tumor that presented with thrombocytosis. Ann Thorac Surg; 2009 Dec;88(6):2013-5
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PEComa (clear cell "sugar" tumor) of the lung: a benign tumor that presented with thrombocytosis.
  • Perivascular epithelioid cell tumors of the lung are rare, benign neoplasms, usually presenting as a solitary pulmonary nodule on chest roentgenograms.
  • This is a case report of a 44-year-old woman who presented with thrombocytosis and solitary pulmonary nodule of the lung, which was removed by a thoracotomy.
  • [MeSH-major] Lung Neoplasms / diagnosis. Perivascular Epithelioid Cell Neoplasms / diagnosis. Thrombocytosis / complications
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Platelet Count. Pneumonectomy. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19932282.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


23. Zhou YA, Huang JH, Wan CY, Zuo ZB: [Surgical treatment and effect observation of cervical intraspinal benign neoplasms]. Zhongguo Gu Shang; 2009 Nov;22(11):856-8
MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical treatment and effect observation of cervical intraspinal benign neoplasms].
  • OBJECTIVE: To investigate the diagnosis, surgical procedure and clinical outcome of cervical intraspinal benign neoplasm.
  • The tumors were removed completely in 18 cases, above 60% in 3 cases and 25% with biopsy in 1 case.
  • Cervical stability in 11 cases was restored after removal of tumors.
  • CONCLUSION: The surgical exairesis for cervical intraspinal benign neoplasm has low post-operative recurrence.
  • The main reason of recurrence is not removed the tumor completely.
  • MRI is regarded the effective method which is helpful in differential diagnosis and surgery guidance.
  • [MeSH-major] Cervical Vertebrae / pathology. Cervical Vertebrae / surgery. Spinal Neoplasms / pathology. Spinal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20084949.001).
  • [ISSN] 1003-0034
  • [Journal-full-title] Zhongguo gu shang = China journal of orthopaedics and traumatology
  • [ISO-abbreviation] Zhongguo Gu Shang
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


24. Li JS, Chen WL, Huang ZQ, Zhang DM: Pediatric mandibular reconstruction after benign tumor ablation using a vascularized fibular flap. J Craniofac Surg; 2009 Mar;20(2):431-4
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pediatric mandibular reconstruction after benign tumor ablation using a vascularized fibular flap.
  • Six pediatric patients ranging in age from 12 to 15 years underwent mandibular reconstruction using a vascularized fibula flap with a skin paddle, after benign tumor ablation.
  • A vascularized fibular flap is a very reliable method for reconstructing the pediatric mandible after benign tumor ablation.
  • [MeSH-major] Bone Transplantation / methods. Mandible / surgery. Mandibular Neoplasms / surgery. Reconstructive Surgical Procedures / methods. Skin Transplantation / methods. Surgical Flaps

  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19218857.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Zou JF, Li JY, Wu XW, Chen SY: [Effects of different anesthesia and analgesia on erythrocyte immune function of patients with ovarian benign tumor treated by laparoscopic therapeutic]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec;26(12):1252-4
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effects of different anesthesia and analgesia on erythrocyte immune function of patients with ovarian benign tumor treated by laparoscopic therapeutic].
  • AIM: To investigate the effects of different anesthesia and analgesia on erythrocyte immune function of patients with ovarian benign tumor treated by laparoscopic therapeutic.
  • METHODS: 120 patients with ovarian benign tumor treated by laparoscopic therapeutic were randomly divided into two groups with 60 cases each.In group A, patients received general anesthesia eombined with thoracic epidural anesthesia during surgery, patients in group B received general anesthesia.
  • CONCLUSION: Anesthesia may harm on erythroeyte immune function of patients with ovarian benign tumor treated by laparoscopic therapeutic.
  • [MeSH-major] Analgesia / adverse effects. Anesthesia / adverse effects. Erythrocytes / immunology. Laparoscopy. Ovarian Neoplasms / immunology. Ovarian Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Anesthesia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21138693.001).
  • [ISSN] 1007-8738
  • [Journal-full-title] Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
  • [ISO-abbreviation] Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Randomized Controlled Trial
  • [Publication-country] China
  •  go-up   go-down


26. Lott S, Lopez-Beltran A, Maclennan GT, Montironi R, Cheng L: Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol; 2007 Jun;38(6):807-23
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential.
  • Most bladder tumors arise from the urothelium.
  • These include both benign and malignant spindle cell lesions.
  • The first half of this 2-part review will describe benign myofibroblastic proliferations including inflammatory myofibroblastic tumor and postoperative spindle cell nodule; benign neoplasms including leiomyoma, hemangioma, neurofibroma, and schwannoma; and tumors of uncertain malignant potential including paraganglioma, granular cell tumor, and perivascular epithelioid cell tumor.
  • This review also describes current theories as to the pathogenesis of inflammatory myofibroblastic tumor and postoperative spindle cell nodule and details the current molecular markers identifying several of these lesions.
  • [MeSH-major] Soft Tissue Neoplasms / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Animals. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Immunohistochemistry

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17509394.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 87
  •  go-up   go-down


27. Mandrell JC, Santa Cruz D: Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol; 2009 Aug;26(3):150-63
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma?
  • They have been considered a benign neoplasm with involution and complete resolution within few months.
  • Although considered the prototypical example of cutaneous pseudomalignancy, some believe that these tumors are squamous cell carcinomas and through the years there have been sporadic reports of "metastasizing keratoacanthomas".
  • The question has been raised as to whether keratoacanthoma is an unreliable histological diagnosis or these tumors have a latent, albeit rare, malignant potential.
  • Since a benign lesion is incapable of metastasis, some other explanation must be considered; the most likely one being a misdiagnosis.
  • While it is clear that in some cases, the histological and cytological features of squamous cell carcinoma and keratoacanthoma are difficult to distinguish by current techniques, these occasional limitations in diagnosis do not make keratoacanthomas a carcinoma.
  • We believe the evidence supports that keratoacanthomas are benign squamous proliferations.
  • The diagnosis can be made with confidence in appropriate biopsies and using well established clinicopathological criteria.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Keratoacanthoma / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Biomarkers / metabolism. Diagnosis, Differential. Diagnostic Errors. Humans. Hyperplasia. Neoplasm Metastasis


28. Bjerggaard MM, Barstad B: [Two cases of multilocular cystic nephroma, a rare benign tumor of the kidney]. Ugeskr Laeger; 2005 Nov 14;167(46):4379-80
MedlinePlus Health Information. consumer health - Kidney Cysts.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Two cases of multilocular cystic nephroma, a rare benign tumor of the kidney].
  • [Transliterated title] To tilfaelde af multilokulaer cystisk nefrom, en sjaelden benign nyretumor.
  • MCN is a rare benign tumor of the kidney that is difficult to differentiate from malignant tumor by diagnostic imaging (ultrasound, CT) and cytology on fine-needle aspiration.
  • This is why most cases end up with nephrectomy and diagnosis is based on the histopathological findings.
  • In one of our two cases, a nephrectomy was performed, and in the other the tumor was resected from the kidney.
  • [MeSH-major] Kidney Diseases, Cystic / diagnosis. Kidney Neoplasms / diagnosis
  • [MeSH-minor] Cystadenoma / diagnosis. Cystadenoma / pathology. Cystadenoma / surgery. Diagnosis, Differential. Female. Humans. Middle Aged. Nephrectomy

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16287525.001).
  • [ISSN] 1603-6824
  • [Journal-full-title] Ugeskrift for laeger
  • [ISO-abbreviation] Ugeskr. Laeg.
  • [Language] dan
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


29. Glick A, Ryscavage A, Perez-Lorenzo R, Hennings H, Yuspa S, Darwiche N: The high-risk benign tumor: evidence from the two-stage skin cancer model and relevance for human cancer. Mol Carcinog; 2007 Aug;46(8):605-10
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The high-risk benign tumor: evidence from the two-stage skin cancer model and relevance for human cancer.
  • Benign tumors that form following chemical initiation and promotion in the mouse skin can be grouped into two classes.
  • The majority of papillomas do not progress to squamous cell carcinoma (SCC), and these are designated as low-risk or terminally benign papillomas.
  • In standard two-stage carcinogenesis studies both tumor types are present, but grossly indistinguishable.
  • [MeSH-major] Carcinoma, Squamous Cell / etiology. Disease Models, Animal. Papilloma / etiology. Skin Neoplasms / etiology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17538943.001).
  • [ISSN] 0899-1987
  • [Journal-full-title] Molecular carcinogenesis
  • [ISO-abbreviation] Mol. Carcinog.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA117957; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Review
  • [Publication-country] United States
  • [Number-of-references] 27
  •  go-up   go-down


30. Yazici P, Aydin U, Ersin S, Kaplan H: Hamartoma - a rare benign tumor of the spleen: a report of four cases. Eurasian J Med; 2008 Apr;40(1):48-51

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hamartoma - a rare benign tumor of the spleen: a report of four cases.
  • Splenic hamartoma is an uncommon benign tumor.
  • Splenic hamartoma must be considered in the differential diagnosis of splenic masses unrelated to any other malignancy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25610025.001).
  • [ISSN] 1308-8734
  • [Journal-full-title] The Eurasian journal of medicine
  • [ISO-abbreviation] Eurasian J Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Turkey
  • [Other-IDs] NLM/ PMC4261320
  • [Keywords] NOTNLM ; Hamartoma / Splenectomy / Splenic mass
  •  go-up   go-down


31. Suwała P, Wilczyński K, Barnaś S, Prudlak E: [A rare case of multiple primary benign neoplasm of parotid gland: oncocytoma and adenolimphoma]. Otolaryngol Pol; 2009 Sep;63(7):89-92

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A rare case of multiple primary benign neoplasm of parotid gland: oncocytoma and adenolimphoma].
  • AIM OF THE WORK: The authors present unusually rare case primary multiple synchronicus benign tumor of the ipsilateral parotid gland: oncocytoma and Warthin's tumor, which is rare among occasionally occurred multiple tumors with different histology in the salivary glands.
  • MATERIAL AND METHOD: A 71-year-old man presented with the tumor in the right parotid gland.
  • The preoperative ultrasonography and macroscopic analysis of the removed parotid gland tissue revealed only one tumor recognised histopathologically as adenolimphoma, but upon histopathological examination Warthin's tumor proved to coexist with oncocytoma.
  • RESULTS AND CONCLUSIONS: In the ultrasonography examination some salivary glands tumors may not be recognised.
  • The histopathological examination is the ultimate method in recognising tumors, which are not detected in the preoperative diagnosis.
  • The superficial parotidectomy protects from the recrudescence of the superficial lobe of the parotid gland tumors.
  • [MeSH-major] Adenolymphoma / pathology. Adenoma, Oxyphilic / pathology. Neoplasms, Multiple Primary / pathology. Parotid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20564910.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


32. Plaut MA, El Mahou S, Popa L, Cantagrel A, Mazières B, Laroche M: Systemic vasculitis revealing a benign tumor: a paraneoplastic syndrome? Joint Bone Spine; 2006 Jul;73(4):462-4
MedlinePlus Health Information. consumer health - Vasculitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Systemic vasculitis revealing a benign tumor: a paraneoplastic syndrome?
  • Systemic vasculitis is a rare event in the course of malignant tumors and has not been described in association with benign tumors.
  • The symptoms resolved fully after tumor excision, supporting a diagnosis of paraneoplastic syndrome.
  • [MeSH-major] Adenoma, Oxyphilic / complications. Kidney Neoplasms / complications. Paraneoplastic Syndromes / complications. Vasculitis / etiology
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged

  • Genetic Alliance. consumer health - Vasculitis.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16807043.001).
  • [ISSN] 1297-319X
  • [Journal-full-title] Joint, bone, spine : revue du rhumatisme
  • [ISO-abbreviation] Joint Bone Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


33. Biswas PK, Niu J, Frederico T, Gogonea V: Numerical simulation and graphical analysis of in vitro benign tumor growth: application of single-particle state bosonic matter equation with length scaling. J Mol Model; 2006 Jul;12(5):641-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Numerical simulation and graphical analysis of in vitro benign tumor growth: application of single-particle state bosonic matter equation with length scaling.
  • We describe the application of a non-linear single-particle state bosonic condensate equation to simulate multicellular tumor growth by treating it as a coupling of two classical wave equations with real components.
  • With one component representing the amplitude of the cells in their volume growth phase and the other representing the amplitude of the cells in their proliferation or mitosis phase, the two components of the coupled equation feed each other during the time evolution and are coupled together through diffusion and other linear and non-linear terms.
  • The features of quiescent and necrotic cells, which result from poor nutrient diffusion into a tumor, have been found to correspond quite well to experimental data when they are modeled as depending on higher cell density.
  • Classical hallmarks of benign tumor growth, such as the initial rapid growth, followed by a dramatic collapse in the proliferating cell count and a strong re-growth thereafter appear quite encouragingly in the theoretical results.
  • A tool for graphical analysis of the tumor simulation results has been developed to provide morphological information about tumors at various growth stages.
  • The model and the graphical analysis can be extended further to create an effective tool to predict/monitor tumor growth.
  • [MeSH-major] Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] In Silico Biol. 2002;2(3):393-406 [12542422.001]
  • [Cites] Phys Rev A. 1995 Feb;51(2):1382-1386 [9911722.001]
  • [Cites] N Engl J Med. 1971 Nov 18;285(21):1182-6 [4938153.001]
  • [Cites] Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1993 Jul;48(1):598-602 [9960624.001]
  • [Cites] J Exp Med. 1973 Oct 1;138(4):745-53 [4744009.001]
  • [Cites] Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1999 Aug;60(2 Pt B):2421-4 [11970045.001]
  • [Cites] J Natl Cancer Inst. 1971 Jan;46(1):113-20 [5101993.001]
  • [Cites] Exp Cell Res. 1971 Apr;65(2):433-8 [4928803.001]
  • [Cites] J Neuropathol Exp Neurol. 1997 Jun;56(6):704-13 [9184661.001]
  • [Cites] Cell Prolif. 1995 Jan;28(1):17-31 [7833383.001]
  • (PMID = 16555065.001).
  • [ISSN] 0948-5023
  • [Journal-full-title] Journal of molecular modeling
  • [ISO-abbreviation] J Mol Model
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] Germany
  •  go-up   go-down


34. Comtesse N, Zippel A, Walle S, Monz D, Backes C, Fischer U, Mayer J, Ludwig N, Hildebrandt A, Keller A, Steudel WI, Lenhof HP, Meese E: Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc Natl Acad Sci U S A; 2005 Jul 5;102(27):9601-6
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
  • There are numerous studies on the immune response against malignant human tumors.
  • This study was aimed to address the complexity and specificity of humoral immune response against a benign human tumor.
  • We assembled a panel of 62 meningioma-expressed antigens that show reactivity with serum antibodies of meningioma patients, including 41 previously uncharacterized antigens by screening of a fetal brain expression library.
  • We detected 17 antigens exclusively with patient sera, including 12 sera that were reactive against KIAA1344, 9 against natural killer tumor recognition (NKTR), and 7 against SRY (sex determining region Y)-box2 (SOX2).
  • Our results show a highly complex but specific humoral immune response against a benign tumor with a distinct serum reactivity pattern and a decline of complexity with malignancy.
  • [MeSH-major] Antibodies, Neoplasm / blood. Antibody Formation / immunology. Antigens, Neoplasm / immunology. Meningioma / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Cancer Res. 1999 Nov;5(11):3560-8 [10589772.001]
  • [Cites] J Exp Med. 1999 Sep 20;190(6):815-26 [10499920.001]
  • [Cites] J Neuropathol Exp Neurol. 2000 Oct;59(10):872-9 [11079777.001]
  • [Cites] Biochem Biophys Res Commun. 2001 May 11;283(3):634-40 [11341771.001]
  • [Cites] Cytogenet Cell Genet. 2001;93(3-4):207-20 [11528114.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jan 18;290(2):830-8 [11785977.001]
  • [Cites] Oncogene. 2002 Jan 10;21(2):239-47 [11803467.001]
  • [Cites] Semin Cancer Biol. 2002 Feb;12(1):25-31 [11926408.001]
  • [Cites] Nat Immunol. 2002 Nov;3(11):999-1005 [12407407.001]
  • [Cites] Int J Cancer. 2003 Mar 10;104(1):73-84 [12532422.001]
  • [Cites] Cancer Immun. 2001 Mar 30;1:4 [12747765.001]
  • [Cites] J Immunol. 2003 Dec 1;171(11):5956-63 [14634107.001]
  • [Cites] Int J Oncol. 2004 Feb;24(2):257-63 [14719100.001]
  • [Cites] Oncogene. 2004 Feb 19;23(7):1420-7 [14691456.001]
  • [Cites] Int J Cancer. 2004 Oct 20;112(1):51-60 [15305375.001]
  • [Cites] Hum Genet. 1987 Dec;77(4):349-51 [2891603.001]
  • [Cites] Cancer Res. 1990 Sep 15;50(18):5863-7 [2393856.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):542-6 [8421688.001]
  • [Cites] Biochem Biophys Res Commun. 1993 Sep 15;195(2):686-96 [8373407.001]
  • [Cites] Nat Genet. 1994 Feb;6(2):180-4 [8162072.001]
  • [Cites] Am J Pathol. 1995 Apr;146(4):827-32 [7717450.001]
  • [Cites] Cancer Res. 1995 Oct 15;55(20):4696-701 [7553651.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810-3 [8524854.001]
  • [Cites] Mol Biol Cell. 1996 Jul;7(7):1015-24 [8862517.001]
  • [Cites] J Neurosurg. 1997 Jan;86(1):113-20 [8988089.001]
  • [Cites] J Biol Chem. 1997 Jul 18;272(29):17907-11 [9218414.001]
  • [Cites] Hum Mol Genet. 1997 Nov;6(12):2031-41 [9356211.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] Hum Mol Genet. 1998 Nov;7(12):1859-72 [9811929.001]
  • [Cites] Nucleic Acids Res. 1999 Mar 15;27(6):1409-20 [10037800.001]
  • [Cites] Blood. 1999 Apr 1;93(7):2158-66 [10090922.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4198-203 [10760287.001]
  • (PMID = 15983380.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Neoplasm; 0 / Antigens, Neoplasm; 0 / DNA Primers
  • [Other-IDs] NLM/ PMC1172238
  •  go-up   go-down


35. Misago N, Narisawa Y: Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation. J Dermatol; 2006 Jan;33(1):2-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation.
  • To clarify the features of apocrine mixed tumors (AMT) of the skin among benign neoplasms with apocrine differentiation in their relationship to follicular stem cells, we investigated the immunohistochemical expression of CK15 (LHK15 and C8/144B), which is a relatively specific marker of hair follicle stem cells in the bulge, in 35 cases of eight different benign neoplasms with presumed apocrine differentiation.
  • All eight cases of AMT of the skin showed CK15 immunostaining of the neoplastic cells, and all four cases of syringocystadenoma papilliferum, all five cases of spiradenoma, and both cases of cylindroma also showed a focally positive reaction to CK15.
  • None of the other benign neoplasms with presumed apocrine differentiation showed CK15 expression.
  • AMT of the skin are unique among benign neoplasms with apocrine differentiation in their substantial and constant CK15 expression, suggesting that they derive from multipotent epithelial stem cells in the bulge.
  • The partially positive reaction for CK15 in syringocystadenomas papilliferum and spiradenoma/cylindroma may depend on the ability to express CK15 in stem cells with an apocrine fate or result from the follicular and apocrine nature of this neoplasm.
  • [MeSH-major] Apocrine Glands / metabolism. Keratins / metabolism. Sweat Gland Neoplasms / metabolism
  • [MeSH-minor] Adenoma, Sweat Gland / metabolism. Adult. Aged. Biomarkers, Tumor. Case-Control Studies. Cystadenoma / metabolism. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16469077.001).
  • [ISSN] 0385-2407
  • [Journal-full-title] The Journal of dermatology
  • [ISO-abbreviation] J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 68238-35-7 / Keratins
  •  go-up   go-down


36. Bierer S, Wülfing C, Bode ME, Pühse G, Brinkmann OA, Hertle L: [Bilateral renal angiomyolipomas with a thrombus in the inferior caval vein. Rare growth pattern of a benign tumor]. Urologe A; 2005 Dec;44(12):1469-72
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bilateral renal angiomyolipomas with a thrombus in the inferior caval vein. Rare growth pattern of a benign tumor].
  • [Transliterated title] Bilaterale renale Angiomyolipome mit Thrombus in der Vena cava inferior. Seltenes Wachstumsverhalten eines benignen Tumors.
  • Renal angiomyolipomas are mesenchymal tumors that are composed of fat tissue, smooth muscle cells and vessels.
  • These are benign tumors, but in rare cases they show a more aggressive growth pattern with invasion into the venous system but without revealing any signs of malignancy.
  • [MeSH-major] Angiomyolipoma / complications. Angiomyolipoma / diagnosis. Kidney Neoplasms / complications. Kidney Neoplasms / diagnosis. Vena Cava, Inferior / pathology. Venous Thrombosis / diagnosis. Venous Thrombosis / etiology
  • [MeSH-minor] Adult. Female. Humans. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Deep Vein Thrombosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nihon Hinyokika Gakkai Zasshi. 2002 Jan;93(1):48-51 [11842540.001]
  • [Cites] J Urol. 1992 Dec;148(6):1885-7 [1433629.001]
  • [Cites] Urology. 2002 Oct;60(4):695-6 [12385937.001]
  • [Cites] J Urol. 2004 Jan;171(1):102-5 [14665854.001]
  • [Cites] Rofo. 1999 Jun;170(6):605-7 [10420915.001]
  • [Cites] AJR Am J Roentgenol. 1995 Jul;165(1):198-9 [7785593.001]
  • [Cites] Nihon Hinyokika Gakkai Zasshi. 1999 Aug;90(8):745-9 [10487052.001]
  • [Cites] J Urol. 1999 Jun;161(6):1900-1 [10332463.001]
  • [Cites] Prog Urol. 1997 Sep;7(4):637-9 [9410325.001]
  • [Cites] Acta Radiol. 1996 Nov;37(6):927-32 [8995468.001]
  • [Cites] J Urol. 1992 May;147(5):1356-8 [1569683.001]
  • [Cites] Nihon Hinyokika Gakkai Zasshi. 1994 Nov;85(11):1687-90 [7807779.001]
  • [Cites] Br J Urol. 1988 Jul;62(1):89-90 [3408879.001]
  • [Cites] J Urol. 1995 Apr;153(4):1205-7 [7869500.001]
  • [Cites] Semin Ultrasound CT MR. 1997 Apr;18(2):100-14 [9163829.001]
  • [Cites] Int J Urol. 1995 Nov;2(5):332-5 [8749954.001]
  • [Cites] J Urol. 1999 Oct;162(4):1371-2 [10492201.001]
  • [Cites] Urol Int. 2001;67(2):168-9 [11490215.001]
  • [Cites] Cardiovasc Intervent Radiol. 1994 May-Jun;17(3):152-4 [8087831.001]
  • [Cites] Scand J Urol Nephrol. 1997 Apr;31(2):189-91 [9165585.001]
  • [Cites] Urol Int. 2003;70(4):332-4 [12740503.001]
  • [Cites] Urology. 1997 Dec;50(6):975-7 [9426735.001]
  • [Cites] J Urol. 1982 Mar;127(3):528-9 [7062431.001]
  • [Cites] Br J Urol. 1994 Sep;74(3):383-5 [7953277.001]
  • [Cites] J Urol. 2003 Sep;170(3):918-9 [12913732.001]
  • [Cites] Urol Radiol. 1987;9(3):152-4 [3326240.001]
  • [Cites] Br J Urol. 1998 May;81(5):773-4 [9634065.001]
  • [Cites] Am J Surg Pathol. 1991 Nov;15(11):1083-8 [1928559.001]
  • [Cites] J Urol. 2002 Oct;168(4 Pt 1):1315-25 [12352384.001]
  • (PMID = 16133230.001).
  • [ISSN] 0340-2592
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


37. Murphy AM, Buck AM, Benson MC, McKiernan JM: Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology; 2009 Jun;73(6):1293-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades.
  • OBJECTIVES: To determine whether the detection of benign renal tumors is increasing and to identity the predictors of benign histologic features.
  • The detection of renal cortical tumors has increased with the increased use of abdominal imaging.
  • Current imaging and biopsy techniques cannot predict the renal tumor histologic features with complete accuracy, and many patients undergo surgery for benign lesions.
  • A cohort of 775 patients with a tumor diameter of <or.0 cm, nonmetastatic disease, and nonfamilial disease was selected.
  • Univariate and multivariate logarithmic regression analyses were used to determine the parameters to predict for benign histologic features.
  • RESULTS: The proportion of renal surgery for benign tumors of <or.0 cm in diameter has increased annually.
  • When patients were stratified by the year of surgery, the proportion of benign tumors was 5.0% before 1998, 15.2% from 1998 to 2003, and 21.2% from 2004 to 2007.
  • The mean diameter of benign and malignant tumors was 3.0 and 3.5 cm, respectively, and the mean tumor diameter significantly decreased during the study period (P = .006).
  • Using multivariate analysis, the year of surgery, tumor diameter, and female sex were independent predictors of benign histologic features (P < .05).
  • Age, incidental diagnosis, body mass index, and race were not significant predictors (P > .05).
  • CONCLUSIONS: Even when controlling for tumor diameter and sex, the incidence of benign tumors detected at renal surgery at our institution has increased significantly in the past 2 decades.
  • [MeSH-major] Kidney Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Urology. 2009 Jun;73(6):1297-8 [19482148.001]
  • [CommentIn] Urology. 2009 Jun;73(6):1298-9 [19482149.001]
  • (PMID = 19371933.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Cornette J, Festen S, van den Hoonaard TL, Steegers EA: Mesenchymal hamartoma of the liver: a benign tumor with deceptive prognosis in the perinatal period. Case report and review of the literature. Fetal Diagn Ther; 2009;25(2):196-202
MedlinePlus Health Information. consumer health - Liver Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal hamartoma of the liver: a benign tumor with deceptive prognosis in the perinatal period. Case report and review of the literature.
  • Hepatic mesenchymal hamartoma are rare benign tumors.
  • Prenatal diagnosis remains challenging.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 S. Karger AG, Basel.
  • (PMID = 19365132.001).
  • [ISSN] 1421-9964
  • [Journal-full-title] Fetal diagnosis and therapy
  • [ISO-abbreviation] Fetal. Diagn. Ther.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 36
  •  go-up   go-down


39. Mautner VF, Asuagbor FA, Dombi E, Fünsterer C, Kluwe L, Wenzel R, Widemann BC, Friedman JM: Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol; 2008 Aug;10(4):593-8
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.
  • People with neurofibromatosis 1 (NF1) have multiple benign neurofibromas and a 10% lifetime risk of developing malignant peripheral nerve sheath tumors (MPNSTs).
  • Most MPNSTs develop from benign plexiform neurofibromas, so the burden of benign tumors may be a risk factor for developing MPNST.
  • We studied 13 NF1 patients with MPNSTs and 26 age- and sex-matched controls (NF1 patients who did not have MPNSTs) with detailed clinical examinations and whole-body MRI to characterize their body burden of internal benign neurofibromas.
  • Close surveillance of these high-risk patients may permit earlier diagnosis and more effective treatment of MPNSTs that develop.
  • [MeSH-major] Magnetic Resonance Imaging. Neurofibromatosis 1 / pathology. Tumor Burden. Whole Body Imaging

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):353-7 [10675220.001]
  • [Cites] J Med Genet. 2002 May;39(5):311-4 [12011145.001]
  • [Cites] J Child Neurol. 2002 Aug;17(8):562-70; discussion 571-2, 646-51 [12403554.001]
  • [Cites] J Child Neurol. 2002 Aug;17(8):573-7; discussion 602-4, 646-51 [12403555.001]
  • [Cites] Am J Hum Genet. 2003 May;72(5):1288-92 [12660952.001]
  • [Cites] Hum Mutat. 2003 Nov;22(5):420 [14517963.001]
  • [Cites] Hum Mutat. 2004 Feb;23(2):111-6 [14722914.001]
  • [Cites] Am J Hum Genet. 2004 Sep;75(3):410-23 [15257518.001]
  • [Cites] Brain. 2004 Sep;127(Pt 9):1993-2009 [15289270.001]
  • [Cites] Surg Gynecol Obstet. 1983 May;156(5):636-40 [6405495.001]
  • [Cites] Cancer. 1986 May 15;57(10):2006-21 [3082508.001]
  • [Cites] Arch Neurol. 1988 May;45(5):575-8 [3128965.001]
  • [Cites] Med Pediatr Oncol. 1994;22(2):78-83 [8259105.001]
  • [Cites] Eur J Surg Oncol. 1995 Feb;21(1):78-82 [7851559.001]
  • [Cites] Arch Pathol Lab Med. 1997 Feb;121(2):139-43 [9126041.001]
  • [Cites] JAMA. 1997 Jul 2;278(1):51-7 [9207339.001]
  • [Cites] Neurology. 1998 Jun;50(6):1755-60 [9633723.001]
  • [Cites] Neuroradiology. 1999 Sep;41(9):625-9 [10525761.001]
  • [Cites] J Med Genet. 2004 Nov;41(11):837-41 [15520408.001]
  • [Cites] Am J Med Genet A. 2005 Jan 1;132A(1):49-53 [15523617.001]
  • [Cites] Hum Genet. 2005 May;116(6):466-75 [15776250.001]
  • [Cites] Anticancer Res. 2005 May-Jun;25(3A):1699-702 [16033085.001]
  • [Cites] Neurology. 2005 Jul 26;65(2):205-11 [16043787.001]
  • [Cites] J Surg Orthop Adv. 2005 Winter;14(4):168-74 [16442014.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32 [16404595.001]
  • [Cites] Semin Pediatr Neurol. 2006 Mar;13(1):2-7 [16818170.001]
  • [Cites] Br J Cancer. 2006 Jul 17;95(2):233-8 [16786042.001]
  • [Cites] Neurology. 2007 Feb 27;68(9):643-7 [17215493.001]
  • [Cites] Lancet Neurol. 2007 Apr;6(4):340-51 [17362838.001]
  • [Cites] Neurosurg Focus. 2007;22(6):E12 [17613203.001]
  • [Cites] Neurosurg Focus. 2007;22(6):E3 [17613220.001]
  • [Cites] Anticancer Res. 2007 Jul-Aug;27(4A):1957-60 [17649804.001]
  • [Cites] AJR Am J Roentgenol. 2007 Oct;189(4):928-35 [17885067.001]
  • [Cites] Ann Dermatol Venereol. 2007 Oct;134(10 Pt 1):735-41 [17978710.001]
  • [Cites] Ann Oncol. 2008 Feb;19(2):390-4 [17932395.001]
  • [Cites] Am J Hum Genet. 2001 May;68(5):1110-8 [11283797.001]
  • [Cites] Arch Pediatr. 2002 Jan;9(1):49-60 [11865551.001]
  • [Cites] J Child Neurol. 2002 Aug;17(8):555-61; discussion 571-2, 646-51 [12403553.001]
  • (PMID = 18559970.001).
  • [ISSN] 1522-8517
  • [Journal-full-title] Neuro-oncology
  • [ISO-abbreviation] Neuro-oncology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2666233
  •  go-up   go-down


40. Bornstein MM, Filippi A, Altermatt HJ, Lambrecht JT, Buser D: [The odontogenic keratocyst--odontogenic cyst or benign tumor?]. Schweiz Monatsschr Zahnmed; 2005;115(2):110-28
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The odontogenic keratocyst--odontogenic cyst or benign tumor?].
  • [Transliterated title] Die odontogene Keratozyste--odontogene Zyste oder benigner Tumor?
  • This led to the tentative suggestion that the keratocyst might be a benign cystic neoplasm rather than simply an odontogenic cyst.

  • MedlinePlus Health Information. consumer health - Jaw Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15771334.001).
  • [ISSN] 0256-2855
  • [Journal-full-title] Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia
  • [ISO-abbreviation] Schweiz Monatsschr Zahnmed
  • [Language] FRE; GER
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 68238-35-7 / Keratins
  • [Number-of-references] 69
  •  go-up   go-down


41. Usunova I, Vladimirov V: [Benign neoplasms of female urethra]. Akush Ginekol (Sofiia); 2009;48(1):31-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Benign neoplasms of female urethra].
  • In clinical practice neoplasms of female urethra are found usually in adult women.
  • They can also be found in adolescent girls and as rare congenital abnormality.
  • Histological sample analysis has provided diagnosis of urethral polyp, caruncle and mucosal prolaps.
  • Collaboration between urologists and gynecologists is essential for early diagnosis, prophylaxis and successful treatment of above mentioned diseases.
  • [MeSH-major] Urethral Neoplasms / diagnosis. Urethral Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19496462.001).
  • [ISSN] 0324-0959
  • [Journal-full-title] Akusherstvo i ginekologii︠a︡
  • [ISO-abbreviation] Akush Ginekol (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


42. Bereman MS, Williams TI, Muddiman DC: Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients. Anal Chem; 2009 Feb 1;81(3):1130-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients.
  • In addition, data are compared among samples derived from 10 healthy controls, 10 controls with a differential diagnosis of benign gynecologic tumors, and 10 diseased epithelial ovarian cancer patients (EOC).
  • However, these same glycans provided a significantly less diagnostic value when used to differentiate EOC from benign tumor control samples with an area under the curve of 0.73.
  • [MeSH-major] Biomarkers, Tumor / blood. Carcinoma / diagnosis. Chromatography, Liquid / methods. Glycoproteins / blood. Ovarian Neoplasms / diagnosis. Polysaccharides / blood. Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods
  • [MeSH-minor] Female. Genital Neoplasms, Female / chemistry. Genital Neoplasms, Female / diagnosis. Humans. Hydrophobic and Hydrophilic Interactions. Lectins / blood. Lectins / chemistry. Male. ROC Curve

  • Genetic Alliance. consumer health - Ovarian cancer.
  • Genetic Alliance. consumer health - Ovarian epithelial cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochim Biophys Acta. 1999 Dec 6;1473(1):4-8 [10580125.001]
  • [Cites] Anal Chem. 2008 Oct 1;80(19):7534-42 [18778038.001]
  • [Cites] Fresenius J Anal Chem. 2000 Mar-Apr;366(6-7):669-76 [11225778.001]
  • [Cites] Biochem J. 2001 Jul 1;357(Pt 1):167-82 [11415447.001]
  • [Cites] Rapid Commun Mass Spectrom. 2001;15(19):1862-8 [11565105.001]
  • [Cites] J Am Soc Mass Spectrom. 2002 Apr;13(4):402-7 [11951978.001]
  • [Cites] Cancer Metastasis Rev. 2001;20(3-4):245-77 [12085965.001]
  • [Cites] Rapid Commun Mass Spectrom. 2002;16(13):1320-9 [12112260.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10231-3 [12149519.001]
  • [Cites] J Chromatogr A. 2002 Aug 30;968(1-2):89-100 [12236519.001]
  • [Cites] Anal Biochem. 2003 May 1;316(1):15-22 [12694722.001]
  • [Cites] Clin Exp Metastasis. 2003;20(2):143-52 [12705635.001]
  • [Cites] J Biol Chem. 2003 Aug 1;278(31):28619-34 [12734200.001]
  • [Cites] Nat Rev Cancer. 2004 Jan;4(1):45-60 [14681689.001]
  • [Cites] Anal Chem. 2004 Feb 1;76(3):833-8 [14750882.001]
  • [Cites] Mass Spectrom Rev. 2004 May-Jun;23(3):161-227 [14966796.001]
  • [Cites] Rapid Commun Mass Spectrom. 2004;18(19):2282-92 [15384149.001]
  • [Cites] J Natl Cancer Inst. 1978 Oct;61(4):961-5 [309009.001]
  • [Cites] J Chromatogr. 1979 Apr 11;162(4):507-28 [528665.001]
  • [Cites] Anal Biochem. 1982 Jan 15;119(2):351-9 [7041698.001]
  • [Cites] Anal Chem. 1990 Feb 1;62(3):248-52 [2305955.001]
  • [Cites] J Chromatogr. 1990 Jan 19;499:177-96 [2324207.001]
  • [Cites] Methods Enzymol. 1990;193:647-60 [2074840.001]
  • [Cites] J Chromatogr. 1993 Sep 3;646(2):317-26 [8408434.001]
  • [Cites] Anal Chem. 1996 Sep 15;68(18):3215-23 [8797382.001]
  • [Cites] Anal Chem. 1997 Nov 15;69(22):4530-5 [9375514.001]
  • [Cites] Anal Chem. 1998 Dec 1;70(23):4951-9 [9852781.001]
  • [Cites] Bioessays. 1999 May;21(5):412-21 [10376012.001]
  • [Cites] Biochemistry. 1964 Jan;3:113-20 [14114492.001]
  • [Cites] Anal Chem. 2005 Feb 1;77(3):886-94 [15679358.001]
  • [Cites] Glycobiology. 2005 Dec;15(12):1332-40 [16037490.001]
  • [Cites] Mol Cell Proteomics. 2005 Dec;4(12):2010-21 [16249172.001]
  • [Cites] Proteomics. 2005 Dec;5(18):4665-72 [16281179.001]
  • [Cites] Glycobiology. 2006 Feb;16(2):132-45 [16177264.001]
  • [Cites] J Chromatogr A. 2006 Jan 27;1103(2):296-306 [16364349.001]
  • [Cites] J Proteome Res. 2006 Jul;5(7):1626-35 [16823970.001]
  • [Cites] Mol Cell Proteomics. 2007 Jan;6(1):43-55 [16847285.001]
  • [Cites] Rapid Commun Mass Spectrom. 2007;21(5):807-11 [17279479.001]
  • [Cites] Anal Chem. 2007 Jul 1;79(13):5051-7 [17539604.001]
  • [Cites] J Proteome Res. 2007 Aug;6(8):2936-62 [17583933.001]
  • [Cites] Biochemistry. 2008 Mar 11;47(10):3155-61 [18260648.001]
  • [Cites] J Proteome Res. 2008 Mar;7(3):1109-17 [18237112.001]
  • [Cites] Proteomics. 2008 Apr;8(7):1384-97 [18318007.001]
  • [Cites] J Proteome Res. 2008 Apr;7(4):1650-9 [18311910.001]
  • [Cites] Anal Bioanal Chem. 2008 May;391(1):289-97 [18327675.001]
  • [Cites] J Proteome Res. 2008 Jun;7(6):2562-8 [18422354.001]
  • [Cites] Clin Chem. 2008 Jul;54(7):1166-75 [18487288.001]
  • [Cites] Anal Chem. 2008 Aug 1;80(15):6119-26 [18593198.001]
  • [Cites] J Am Soc Mass Spectrom. 2008 Aug;19(8):1138-46 [18511294.001]
  • [Cites] J Mass Spectrom. 2008 Sep;43(9):1215-23 [18324610.001]
  • [Cites] J Proteome Res. 2008 Sep;7(9):3776-88 [18642944.001]
  • [Cites] Mass Spectrom Rev. 1999 Nov-Dec;18(6):349-450 [10639030.001]
  • (PMID = 19113831.001).
  • [ISSN] 1520-6882
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R33 CA105295; United States / NCI NIH HHS / CA / R33 CA105295
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Glycoproteins; 0 / Lectins; 0 / Polysaccharides; 0 / fucose-binding lectin
  • [Other-IDs] NLM/ NIHMS496567; NLM/ PMC3739471
  •  go-up   go-down


43. Vilallonga R, Espin Basany E, Armengol M: Cavernous hemangioma: unusual benign tumor of the transverse colon. Turk J Gastroenterol; 2009 Jun;20(2):146-9
MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cavernous hemangioma: unusual benign tumor of the transverse colon.
  • Cavernous hemangioma of the colon is an uncommon disease and a rare cause of bleeding.
  • The rectosigmoid is the most common site of this disease in the gastrointestinal tract, while colonic localization is very uncommon.
  • We report the case of a 66-year-old female with recurrent episodes of rectal bleeding.
  • This tumor can be diagnosed as solitary, multiple, or part of a more complex syndrome with cutaneous manifestations.
  • The extension of the lesion, its morphology and its localization can be established, but imaging such as magnetic resonance or computerized tomography scan has to be performed.
  • Sometimes, however, recognition of these tumors is difficult and can be a cause of failed surgical treatment and severe complications.
  • [MeSH-major] Colonic Neoplasms / diagnosis. Gastrointestinal Hemorrhage / diagnosis. Hemangioma, Cavernous / diagnosis

  • Genetic Alliance. consumer health - Hemangioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19530050.001).
  • [ISSN] 2148-5607
  • [Journal-full-title] The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
  • [ISO-abbreviation] Turk J Gastroenterol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


44. Mascarenhas F, Costa MS, Ortiz M, Almeida A, Carvalho H, Ferreira AG, Cattoni MB: [Stereotactic radiosurgery in the intracranial benign neoplasms and malignant tumors of the brain]. Acta Med Port; 2005 Jan-Feb;18(1):45-60
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Stereotactic radiosurgery in the intracranial benign neoplasms and malignant tumors of the brain].
  • Stereotactic Radiosurgery has proven to be during the last years the therapy of choice in more and more patients with benign and malignant brain tumors.
  • This series presents the experience of treating more than 100 intracranial lesions with linear accelerator-based radiosurgery at Hospital de Santa Maria in Lisbon with special emphasis on the indications and results.
  • It also provides a review of the concepts and procedures of this modality as well as a general overview of the main published results in series of patients with brain tumors treated with stereotactic radiosurgery.
  • [MeSH-major] Brain Neoplasms / surgery. Radiosurgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16202334.001).
  • [ISSN] 1646-0758
  • [Journal-full-title] Acta médica portuguesa
  • [ISO-abbreviation] Acta Med Port
  • [Language] por
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Portugal
  •  go-up   go-down


45. Li Y, Liang Q, Wen YQ, Chen LL, Wang LT, Liu YL, Luo CQ, Liang HZ, Li MT, Li Z: Comparative proteomics analysis of human osteosarcomas and benign tumor of bone. Cancer Genet Cytogenet; 2010 Apr 15;198(2):97-106
antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
  • Proteins extracted from osteosarcoma tissue and benign bone tumors, including osteoblastoma, chondroblastoma, and giant cell tumor of bone, were examined using two-dimensional gel electrophoresis followed by mass spectrometry analysis and database searches.
  • Aberrant expression of cytoskeletal- and microtubule-associated proteins in osteosarcoma may provide an advantage for tumor invasion and metastasis by affecting the stability of microtubule, which consequently influences the prognosis of patients.
  • [MeSH-major] Bone Neoplasms / metabolism. Neoplasm Proteins / analysis. Osteoblastoma / metabolism. Osteosarcoma / metabolism. Proteomics / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / analysis. Biomarkers, Tumor / metabolism. Bone and Bones / metabolism. Bone and Bones / pathology. Child. Chondroblastoma / metabolism. Chondroblastoma / pathology. Female. Giant Cell Tumor of Bone / metabolism. Giant Cell Tumor of Bone / pathology. Humans. Male. Middle Aged. Proteome / analysis. Proteome / metabolism. Young Adult


46. Leow LJ, Sinclair PA, Horton JJ: Plaque-like dermatofibroma: A distinct and rare benign neoplasm? Australas J Dermatol; 2008 May;49(2):106-8
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Plaque-like dermatofibroma: A distinct and rare benign neoplasm?
  • Based on the histological findings, a diagnosis of dermatofibroma was made for each of these cases.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Skin / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Dermatofibroma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18412813.001).
  • [ISSN] 1440-0960
  • [Journal-full-title] The Australasian journal of dermatology
  • [ISO-abbreviation] Australas. J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


47. Venkatesh K, Saini ML, Rangaswamy R, Murthy S: Neural fibrolipoma without macrodactyly: a subcutaneous rare benign tumor. J Cutan Pathol; 2009 May;36(5):594-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neural fibrolipoma without macrodactyly: a subcutaneous rare benign tumor.
  • Neural fibrolipoma, also known as lipofibromatous hamartoma of nerves and neurolipomatosis, is a rare subcutaneous benign lesion involving the upper extremity with a marked predilection for median nerve.
  • Knowledge of characteristic histological and radiological findings is necessary for diagnosis and treatment.
  • [MeSH-minor] Adult. Fibroma / pathology. Fibroma / surgery. Fingers / pathology. Hand / pathology. Hand / surgery. Humans. Male. Peripheral Nervous System Neoplasms / pathology. Peripheral Nervous System Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19476532.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


48. Castelnuovo P, Giovannetti F, Bignami M, Ungari C, Iannetti G: Open surgery versus endoscopic surgery in benign neoplasm involving the frontal sinus. J Craniofac Surg; 2009 Jan;20(1):180-3
MedlinePlus Health Information. consumer health - Endoscopy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Open surgery versus endoscopic surgery in benign neoplasm involving the frontal sinus.
  • Indeed, its anatomic opening (ostium) is strictly related to a complex ethmoidal structure prechamber mainly composed of the frontal recess.This constitutional feature makes the endoscopic approach more complex in comparison with other major sinuses treatment.In the following work, we present a systematization of surgical approach in relation to different pathologies, analyzing differences and results throughout the comparison of 2 groups: one treated with the endoscopic approach, and the other with open surgery.From these observations, we can assess that surgical approach choice must consider several parameters such as neoplasm localization, extension, dimension, and frontal recess anatomic features.
  • [MeSH-major] Craniotomy / methods. Endoscopy / methods. Frontal Sinus / surgery. Paranasal Sinus Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19165022.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Karthikeyan P, Paulraj P: An unusual benign tumor of pinna - A case report. Indian J Otolaryngol Head Neck Surg; 2010 Jun;62(2):195-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual benign tumor of pinna - A case report.
  • This case is being reported as it is a rare skin adnexal tumor arising from an unusual site.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23120714.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450310
  • [Keywords] NOTNLM ; Hamartoma / Skin adnexal tumor / Tricho folliculoma
  •  go-up   go-down


50. Haruki T, Nakamura H, Taniguchi Y, Miwa K, Adachi Y, Fujioka S: Pulmonary mucinous cystadenoma: a rare benign tumor of the lung. Gen Thorac Cardiovasc Surg; 2010 Jun;58(6):287-90
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary mucinous cystadenoma: a rare benign tumor of the lung.
  • This tumor is histologically characterized by a benign proliferation of mucin-producing epithelial cells and bulky mucin inside the tumor.
  • We present the case of a 71-year-old woman with increasing mass shadow on chest radiography who underwent tumor resection by video-assisted thoracic surgery.
  • The tumor was diagnosed histologically as PMCA.
  • [MeSH-major] Cystadenoma, Mucinous. Lung Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20549459.001).
  • [ISSN] 1863-6713
  • [Journal-full-title] General thoracic and cardiovascular surgery
  • [ISO-abbreviation] Gen Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


51. Adam C, Polivka M, Carpentier A, George B, Gray F: Papillary glioneuronal tumor: not always a benign tumor? Clin Neuropathol; 2007 May-Jun;26(3):119-24
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary glioneuronal tumor: not always a benign tumor?
  • Papillary glioneuronal tumor (PGNT) is a variant of ganglioglioma, characterized by a pseudopapillary structure with a single pseudostratified layer of small, cuboidal, GFAP-positive cells around hyalinized blood vessels.
  • To date, less than 30 cases have been described with a usually benign course.
  • We report two additional cases: a clinically, radiologically and histopathologically typical tumor in a 38-year-old man and an atypical tumor with histopathological features of anaplasia in a 74-year-old woman.
  • The latter tumor showed the classical pseudopapillary pattern with ganglioid cells and some astrocytes between the papillae, but also had changes suggestive of anaplasia including necrosis, capillary endothelial proliferation, mitoses, dedifferentiation with loss of GFAP expression of the cuboidal cells and increased Ki-67 labeling of over 10%.
  • [MeSH-major] Brain Neoplasms / pathology. Ganglioglioma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19157003.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


52. Diniz MB, Giro Elisa MA, Zuanon Angela CC, Costa CA, Hebling J: Congenital epulis: a rare benign tumor in the newborn. J Indian Soc Pedod Prev Dent; 2010 Jul-Sep;28(3):230-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital epulis: a rare benign tumor in the newborn.
  • Congenital epulis (CE) of the newborn is a rare benign soft tissue tumor that presents at birth.
  • A decisive diagnosis is made by histopathologic analysis as other newborn lesions can be incorrectly diagnosed as CE.
  • This article presents a case report of a female infant who presented a fibrotic mass in the primary lateral incisor and canine region of the maxillary alveolar ridge.
  • [MeSH-major] Gingival Neoplasms / congenital. Gingival Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21157060.001).
  • [ISSN] 0970-4388
  • [Journal-full-title] Journal of the Indian Society of Pedodontics and Preventive Dentistry
  • [ISO-abbreviation] J Indian Soc Pedod Prev Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


53. Marques YM, de Lima Mde D, de Melo Alves Sde M Jr, Soares FA, de Araújo VC, Pinto Ddos S Jr, Mantesso A: Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland. Oral Oncol; 2008 Sep;44(9):903-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.
  • The pAkt protein is closely related to Mdm2, and has not been previously reported in salivary gland tumors.
  • Overexpression of Mdm2 and pAkt was present in all the cell lines and tumors studied, whereas the expression of p53 and p21 proteins was considered absent.
  • In conclusion, the signaling pathway in benign salivary gland neoplasm showed an important participation of Mdm2 overexpression protein in tumor formation, progression through inactivation of p53 action, or both, and of pAkt overexpression through increased translocation of Mdm2 protein to cellular nuclei.
  • [MeSH-major] Cyclin-Dependent Kinase Inhibitor p21 / metabolism. Proto-Oncogene Proteins c-akt / metabolism. Proto-Oncogene Proteins c-mdm2 / metabolism. Salivary Gland Neoplasms / metabolism. Tumor Suppressor Protein p53 / metabolism
  • [MeSH-minor] Cell Line, Tumor. Genes, p53 / genetics. Humans. Immunohistochemistry. Mutation. Signal Transduction / genetics

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18485798.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CDKN1A protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Tumor Suppressor Protein p53; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 6.3.2.19 / Proto-Oncogene Proteins c-mdm2
  •  go-up   go-down


54. Riesz P, Székely E, Törzsök P, Majoros A, Szendroi A, Dombovári P, Romics I: [Can inverted papilloma in urinary bladder be considered as a benign tumor]. Orv Hetil; 2010 Jan 17;151(3):92-5
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Can inverted papilloma in urinary bladder be considered as a benign tumor].
  • [Transliterated title] Jóindulatú daganat-e a húgyhólyag invertált papillomája?
  • According to literature data, this disease is not malignant, and has low recurrence rate.
  • In one case, inverted papilloma and transitiocellular tumor (pTa G1) were detected.
  • CONCLUSIONS: Based on authors' experience, inverted papilloma of the urinary bladder is a benign lesion, but malignant changes or concomitant transitiocellular tumor may occur, thus follow-up is needed.
  • [MeSH-major] Neoplasm Recurrence, Local / pathology. Papilloma, Inverted / pathology. Papilloma, Inverted / surgery. Precancerous Conditions / pathology. Urinary Bladder Neoplasms / pathology. Urinary Bladder Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20061266.001).
  • [ISSN] 0030-6002
  • [Journal-full-title] Orvosi hetilap
  • [ISO-abbreviation] Orv Hetil
  • [Language] hun
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


55. Sumi T, Tsunoda A, Shirakura S, Kishimoto S: Mechanical obstruction of the eustachian tube by the benign tumor of the parapharyngeal space does not cause otitis media with effusion. Otol Neurotol; 2007 Dec;28(8):1072-5
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mechanical obstruction of the eustachian tube by the benign tumor of the parapharyngeal space does not cause otitis media with effusion.
  • OBJECTIVE: We are reporting on eustachian tube and middle ear pathologic findings in patients with parapharyngeal tumors.
  • PATIENTS: Eleven cases of eustachian tube involvement as indicated by obstruction due to compression of the tumor were assessed in this study.
  • RESULTS: All of the tumors were diagnosed benign according to the histologic examination.
  • In 9 of the 11 patients, the pharyngeal opening of the eustachian tube narrowed or was blocked by the tumor.
  • None of the patients showed any response on the tumor side in the sonotubometry.
  • Therefore, gas exchange was prevented through the eustachian tube by the tumor; however, they also showed an intact tympanic membrane and normal hearing tests.
  • [MeSH-major] Adenoma / complications. Eustachian Tube. Otitis Media with Effusion / etiology. Pharyngeal Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18084819.001).
  • [ISSN] 1531-7129
  • [Journal-full-title] Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • [ISO-abbreviation] Otol. Neurotol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Sumiyoshi T, Sumiyoshi C, Nohara S, Hagino H, Hasegawa S, Kuwayama N, Endo S, Kurachi M: Verbal memory deficits in a preadolescent case of lesions of the left parahippocampal gyrus associated with a benign tumor. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun;30(4):733-6
MedlinePlus Health Information. consumer health - Memory.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Verbal memory deficits in a preadolescent case of lesions of the left parahippocampal gyrus associated with a benign tumor.
  • The authors report cognitive functions of a 13-year-old boy with a cavernous angioma occupying the posterior left parahippocampal gyrus (PHG) and part of the left fusiform gyrus but not hippocampus.
  • Neuropsychological examinations soon after the removal of the tumor showed selective deficits in semantic memory function, as evaluated by the Category Fluency Task and the Wechsler Memory Scale-Revised, while visual memory, attention, and IQ were not affected.
  • [MeSH-major] Brain Neoplasms / physiopathology. Hemangioma, Cavernous / physiopathology. Memory Disorders / pathology. Parahippocampal Gyrus / pathology. Verbal Learning / physiology

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16442196.001).
  • [ISSN] 0278-5846
  • [Journal-full-title] Progress in neuro-psychopharmacology & biological psychiatry
  • [ISO-abbreviation] Prog. Neuropsychopharmacol. Biol. Psychiatry
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


57. Maheshwari R, Thool A: Orbital cavernous hemangioma of childhood. Indian J Ophthalmol; 2007 Jul-Aug;55(4):313-5
Genetic Alliance. consumer health - Hemangioma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ocular and orbital tumors, both benign and malignant, occur relatively frequently in infants and children.
  • Benign masses are much more common than malignant in the orbital region.
  • However, childhood tumors show great variability and it is difficult to differentiate benign from malignant lesions.
  • Cavernous hemangioma is the most common benign neoplasm of the orbit in adults.
  • [MeSH-major] Hemangioma, Cavernous / diagnosis. Orbital Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17595488.001).
  • [ISSN] 0301-4738
  • [Journal-full-title] Indian journal of ophthalmology
  • [ISO-abbreviation] Indian J Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


58. Jung HS, Choi SH, Noh JH, Ohi SH, Ahn YR, Lee MK, Kim KW: Healthy twin birth after autologous islet transplantation in a pancreatectomized patient due to a benign tumor. Transplant Proc; 2007 Jun;39(5):1723-5
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Healthy twin birth after autologous islet transplantation in a pancreatectomized patient due to a benign tumor.
  • PATIENT: A 35-year-old woman who underwent distal pancreatectomy owing to a solid pseudopapillary neoplasm received an autologous islet transplantation (140,000 islet equivalents).
  • [MeSH-major] Islets of Langerhans Transplantation / physiology. Pancreatectomy. Pancreatic Neoplasms / surgery

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Islet Cell Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17580233.001).
  • [ISSN] 0041-1345
  • [Journal-full-title] Transplantation proceedings
  • [ISO-abbreviation] Transplant. Proc.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


59. Popescu I, Tomulescu V, Hrehoret D, Popescu A, Herlea V: Laparoscopic hand-assisted adrenalectomy for a 20 cm benign tumor. Chirurgia (Bucur); 2007 Jan-Feb;102(1):75-8
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic hand-assisted adrenalectomy for a 20 cm benign tumor.
  • Since its introduction in 1992, laparoscopic adrenalectomy (LA) has become the technique of choice in the surgical treatment of both secreting or non-secreting benign adrenal pathology.
  • Although traditionally, laparoscopic approach was recommended only for tumor sizes less than 6-8 cm--as larger tumors were known to have an increased risk of malignancy--the currently growing experience and improvement of surgical techniques has allowed for an extension of the therapeutic indication, as shown by the recent case report of LA use for a benign 22 cm tumor (1).
  • We report the case of a young patient operated in our Department for a benign 20 cm adrenal tumor for which laparoscopic "hand-assisted" adrenalectomy yielded a good postoperative outcome and minimal complications.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy. Laparoscopy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17410734.001).
  • [ISSN] 1221-9118
  • [Journal-full-title] Chirurgia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Chirurgia (Bucur)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


60. Kaddoura I, Zaatari G: Fibro-osseous pseudotumor of the thenar eminence: a rare aggressive but benign tumor. Ann Plast Surg; 2009 Mar;62(3):326-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fibro-osseous pseudotumor of the thenar eminence: a rare aggressive but benign tumor.
  • Fibro-osseous pseudotumor is a rare benign lesion that is characterized by fibroblastic proliferation with foci of osseous differentiation.
  • The tumor commonly involves the digits and is usually mistaken for malignancy because of its aggressive nature thus resulting in surgical over treatment.
  • [MeSH-major] Soft Tissue Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19240534.001).
  • [ISSN] 1536-3708
  • [Journal-full-title] Annals of plastic surgery
  • [ISO-abbreviation] Ann Plast Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. Leaha C, Opris I, Macé P, Resch B, Sabourin JC: [Cystic adenomatoid tumor of the uterus]. Ann Pathol; 2009 Apr;29(2):134-7
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cystic adenomatoid tumor of the uterus].
  • [Transliterated title] Tumeur adénomatoïde kystique utérine.
  • Adenomatoid tumors are benign neoplasms of mesothelial origin, which involve the feminine and masculine genital tracts.
  • Our study presents an adenomatoid tumour, of cystic shape, which enables discussion of the histogenesis of this tumour and enlightenment of differential diagnoses which can at times result in an incorrect malignant diagnosis.
  • [MeSH-major] Adenomatoid Tumor / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Calbindin 2. Carcinoma, Signet Ring Cell / pathology. Diagnosis, Differential. Epithelium / pathology. Female. Humans. Male. Myometrium / pathology. S100 Calcium Binding Protein G / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19364588.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Calbindin 2; 0 / S100 Calcium Binding Protein G
  •  go-up   go-down


62. Dilsiz A, Aydin T, Gursan N: Capillary hemangioma as a rare benign tumor of the oral cavity: a case report. Cases J; 2009;2:8622

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Capillary hemangioma as a rare benign tumor of the oral cavity: a case report.
  • INTRODUCTION: Hemangioma is a relatively common benign proliferation of blood vessels that primarily develops during childhood.
  • Cavernous hemangioma appears as an elevated lesion of a deep red color, and consists of large dilated sinuses filled with blood.
  • The purpose of the study was to report the case of a capillary hemangioma in a patient and to describe the successful treatment of this case.
  • Early detection and biopsy is necessary to determine the clinical behavior of the tumor and potential dentoalveolar complications.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Ophthalmol. 1992 Dec;110(12):1743-7 [1463416.001]
  • [Cites] Cases J. 2009;2(1):80 [19161627.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1990 Sep;70(3):268-73 [2216353.001]
  • [Cites] J Periodontol. 1974 Aug;45(8):601-7 [4529305.001]
  • [Cites] J Periodontol. 1973 Sep;44(9):579-82 [4543218.001]
  • [Cites] Am J Surg Pathol. 1980 Oct;4(5):470-9 [7435775.001]
  • [Cites] Ann Plast Surg. 2000 Feb;44(2):188-94 [10696047.001]
  • [Cites] Neuroradiology. 2000 Mar;42(3):215-7 [10772147.001]
  • [Cites] Int J Paediatr Dent. 2000 Jun;10(2):161-5 [11310103.001]
  • [Cites] Br J Oral Maxillofac Surg. 2002 Dec;40(6):497-503 [12464208.001]
  • [Cites] Ann Diagn Pathol. 2002 Dec;6(6):339-44 [12478482.001]
  • [Cites] Acta Chir Plast. 2003;45(2):55-60 [12921261.001]
  • [Cites] Pediatr Surg Int. 2003 Nov;19(9-10):639-45 [14600772.001]
  • [Cites] J Craniofac Surg. 2004 Jan;15(1):82-3 [14704569.001]
  • [Cites] Pediatr Dent. 2007 May-Jun;29(3):239-42 [17688022.001]
  • [Cites] J Periodontol. 2008 Mar;79(3):549-55 [18315439.001]
  • [Cites] Pediatr Clin North Am. 1991 Aug;38(4):811-34 [1870907.001]
  • (PMID = 20181211.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2827094
  •  go-up   go-down


63. Jiang Y, Chen Y, Gao L, Ye Q, Alonso MA: [Expression pattern of MAL in normal epithelial cells, benign tumor, and squamous cell carcinoma of larynx]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 May;23(10):451-3
Genetic Alliance. consumer health - Carcinoma, Squamous Cell.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression pattern of MAL in normal epithelial cells, benign tumor, and squamous cell carcinoma of larynx].
  • MAL, therefore, is a potential marker for early diagnosis of laryngeal squamous cell carcinoma.
  • [MeSH-major] Carcinoma, Squamous Cell / metabolism. Laryngeal Mucosa / metabolism. Laryngeal Neoplasms / metabolism. Membrane Transport Proteins / metabolism. Myelin Proteins / metabolism. Proteolipids / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19670627.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / MAL protein, human; 0 / Membrane Transport Proteins; 0 / Myelin Proteins; 0 / Myelin and Lymphocyte-Associated Proteolipid Proteins; 0 / Proteolipids
  •  go-up   go-down


64. Mangioni S, Viganò P, Lattuada D, Abbiati A, Vignali M, Di Blasio AM: Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor. J Clin Endocrinol Metab; 2005 Sep;90(9):5349-55
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor.
  • CONTEXT: Uterine leiomyomas are the most common tumors in the human female pelvis and the leading indication for pelvic surgery.
  • The molecular causes of the disease remain unknown.
  • Treatment with 9-cis retinoic acid significantly inhibited Wnt5b expression in myometrial SMC but not in their leiomyoma counterparts.
  • [MeSH-major] Leiomyoma / metabolism. Proto-Oncogene Proteins / metabolism. Signal Transduction. Uterine Neoplasms / metabolism

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15972578.001).
  • [ISSN] 0021-972X
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Membrane Proteins; 0 / Proto-Oncogene Proteins; 0 / RNA, Messenger; 0 / SFRP1 protein, human; 0 / WNT5B protein, human; 0 / Wnt Proteins
  •  go-up   go-down


65. Alibegov RA, Narezkin DV, Sergeev OA, Prokhorenko TI, Zhvitiashvili ID: [Choice and specificities of formation of pancreaticodigestive anastomosis in proximal resections of the pancreas]. Vestn Khir Im I I Grek; 2010;169(6):72-4
MedlinePlus Health Information. consumer health - Pancreatic Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The authors describe the direct results of 116 proximal resections of the pancreas made for tumor and benign diseases of the pancreas head and periampular zone.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21400818.001).
  • [ISSN] 0042-4625
  • [Journal-full-title] Vestnik khirurgii imeni I. I. Grekova
  • [ISO-abbreviation] Vestn. Khir. Im. I. I. Grek.
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


66. Zarbis N, Barth TF, Blumstein NM, Schelzig H: Pecoma of the lung: a benign tumor with extensive 18F-2-deoxy-D-glucose uptake. Interact Cardiovasc Thorac Surg; 2007 Oct;6(5):676-8
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pecoma of the lung: a benign tumor with extensive 18F-2-deoxy-D-glucose uptake.
  • A case of lung pecoma (i.e. tumors showing perivascular epithelioid cell differentiation) with extensive 18F-2-deoxy-D-glucose (FDG) uptake in PET/CT study is reported.
  • Pecomas of the lung--which include the better known clear cell 'sugar' tumor--are a subset of extremely rare lung tumors which usually react positively to both melanocytic and smooth muscle markers.
  • Although widely presumed as benign in computed tomography (CT) and positron emission tomography (PET)/CT studies they depict as malignant, thus complicating the preoperative diagnosis.
  • [MeSH-major] Cell Differentiation. Epithelioid Cells / pathology. Fluorodeoxyglucose F18. Lung Neoplasms / radionuclide imaging. Positron-Emission Tomography. Radiopharmaceuticals

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17670735.001).
  • [ISSN] 1569-9285
  • [Journal-full-title] Interactive cardiovascular and thoracic surgery
  • [ISO-abbreviation] Interact Cardiovasc Thorac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


67. Burke A, Li L, Kling E, Kutys R, Virmani R, Miettinen M: Cardiac inflammatory myofibroblastic tumor: a "benign" neoplasm that may result in syncope, myocardial infarction, and sudden death. Am J Surg Pathol; 2007 Jul;31(7):1115-22
MedlinePlus Health Information. consumer health - Heart Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cardiac inflammatory myofibroblastic tumor: a "benign" neoplasm that may result in syncope, myocardial infarction, and sudden death.
  • Cardiac tumors other than myxomas are rare.
  • All tumors were surgical resections, except 1 tumor that resulted in sudden coronary death and that was diagnosed at autopsy, and 1 tumor that embolized into the coronary artery and was treated by cardiac transplant.
  • Two tumors, present in the aortic and mitral valves, respectively, caused cardiac ischemia.
  • The tumors were polypoid or filiform and histologically resembled inflammatory myofibroblastic tumors of extracardiac sites, with loose spindle cell growth with sparse inflammation.
  • Although there were frequent collagen bundles interspersed among the tumor cells, there were no large areas of dense fibrosis.
  • Long-term follow-up in 2 patients demonstrated no evidence of disease or recurrence.
  • Although metastatic potential was not identified, these tumors may result in serious symptoms, including myocardial infarct, syncope, and sudden death.
  • These cardiac myofibroblastic tumors are readily distinguished from other endocardial-based cardiac tumors, including papillary fibroelastoma and myxoma, which may present clinically in the same manner.


68. Calbo L, Sciglitano P, Calbo E, Niceta M, Borzì R, Sofia L, Plutino F, Gorgone S: [Carotid body tumor. An often misdiagnosed disease]. G Chir; 2009 Apr;30(4):144-7
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Carotid body tumor. An often misdiagnosed disease].
  • Chemodectomas are uncommon neoplasms, born by glomic cell of extra-adrenegic system.
  • Usually, these neoplasms are benign and non functioning, but when they are more than 4 cm can induce a neuro-vascular compressive syndrome.
  • In this study the Authors propose the guidelines for diagnostic, clinical and therapeutic management, of these tumors according to their experience.
  • [MeSH-major] Carotid Body Tumor / diagnosis. Head and Neck Neoplasms / diagnosis. Paraganglioma, Extra-Adrenal / diagnosis

  • Genetic Alliance. consumer health - Carotid Body Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19419614.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


69. Larumbe A, Iglesias ME, Illarramendi JJ, Córdoba A, Gállego M: [Acral keratoses and inverted follicular keratosis presenting Cowden disease]. Actas Dermosifiliogr; 2007 Jul-Aug;98(6):425-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Acral keratoses and inverted follicular keratosis presenting Cowden disease].
  • [Transliterated title] Queratosis acras y queratosis folicular invertida como manifestación de la enfermedad de Cowden.
  • Cowden disease is a rare genetic disorder characterized by the presence of multiple hamartomas in the skin, thyroid, breast, nervous system and gastrointestinal tract.
  • Breast and thyroid neoplasms (benign and malignant) develop in up to two thirds of patients.
  • Inverted follicular keratosis as the presenting feature of Cowden disease is rare as the disease is usually suspected by the appearance of multiple facial trichilemmomas, oral mucosal papillomatosis and acral keratoses.
  • [MeSH-major] Hamartoma Syndrome, Multiple / diagnosis. Keratosis / etiology
  • [MeSH-minor] Adenocarcinoma / genetics. Breast Neoplasms / genetics. Endometrial Neoplasms / genetics. Female. Goiter, Nodular / genetics. Humans. Lymphangioma / etiology. Mastectomy. Middle Aged. Postoperative Complications / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17663933.001).
  • [ISSN] 0001-7310
  • [Journal-full-title] Actas dermo-sifiliográficas
  • [ISO-abbreviation] Actas Dermosifiliogr
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


70. Carpizo DR, Allen PJ, Brennan MF: Current management of cystic neoplasms of the pancreas. Surgeon; 2008 Oct;6(5):298-307
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Current management of cystic neoplasms of the pancreas.
  • The majority of these cysts represent benign neoplasms; however, a significant fraction of these are pre-malignant or malignant.
  • Because the majority of these neoplasms are benign, many reports have advocated a selective approach to surgical resection.
  • Here we review the literature that has contributed to the development of our approach to the management of these cystic neoplasms.
  • We provide an overview of the key features in diagnosis and in predicting malignancy.
  • Particular attention is given to the natural history and management of intraductal papillary mucinous neoplasms (IPMN).
  • [MeSH-major] Cystadenoma / surgery. Pancreatic Cyst / surgery. Pancreatic Neoplasms / surgery
  • [MeSH-minor] Combined Modality Therapy. Diagnosis, Differential. Diagnostic Imaging. Humans

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18939378.001).
  • [ISSN] 1479-666X
  • [Journal-full-title] The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
  • [ISO-abbreviation] Surgeon
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Scotland
  • [Number-of-references] 51
  •  go-up   go-down


71. Klöppel G, Rindi G, Anlauf M, Perren A, Komminoth P: Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch; 2007 Aug;451 Suppl 1:S9-27
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.
  • The gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are composed of cells with a neuroendocrine phenotype.
  • Well-differentiated tumors, well-differentiated carcinomas, poorly differentiated carcinomas, functioning tumors (with a hormonal syndrome), and nonfunctioning tumors are identified.
  • To predict their clinical behavior, these neuroendocrine tumors are classified on the basis of their clinicopathological features, including size, local invasion, angioinvasion, proliferative activity, histological differentiation, and metastases, into neoplasms with benign, uncertain, low-grade malignant and high-grade malignant behavior.
  • In addition, a tumor/nodes/metastases classification and a grading system are presented.
  • [MeSH-major] Digestive System Neoplasms / classification. Digestive System Neoplasms / pathology. Neuroendocrine Tumors / classification. Neuroendocrine Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1984 Dec;8(12):917-24 [6097131.001]
  • [Cites] Surgery. 1986 Jun;99(6):671-8 [2424108.001]
  • [Cites] Am J Surg. 1980 May;139(5):682-90 [6258453.001]
  • [Cites] J Clin Oncol. 2002 Jun 1;20(11):2633-42 [12039924.001]
  • [Cites] Am J Surg. 1964 Aug;108:132-41 [14195205.001]
  • [Cites] Virchows Arch. 1995;425(6):547-60 [7697211.001]
  • [Cites] Surgery. 1992 Apr;111(4):466-71 [1557693.001]
  • [Cites] Am J Surg Pathol. 2002 Apr;26(4):517-22 [11914632.001]
  • [Cites] Cancer. 1991 Sep 15;68(6):1329-34 [1678681.001]
  • [Cites] Virchows Arch. 2006 Oct;449(4):395-401 [16967267.001]
  • [Cites] Lancet. 1977 Mar 26;1(8013):666-8 [66472.001]
  • [Cites] Medicine (Baltimore). 1949 Dec;28(4):427-47 [15399004.001]
  • [Cites] Virchows Arch. 2003 Jun;442(6):605-10 [12734754.001]
  • [Cites] Cancer. 1997 Feb 15;79(4):813-29 [9024720.001]
  • [Cites] Am J Surg Pathol. 2003 Jun;27(6):811-7 [12766586.001]
  • [Cites] Virchows Arch. 2006 Apr;448(4):394-8 [16418841.001]
  • [Cites] Ann Surg. 1981 Feb;193(2):185-90 [6258500.001]
  • [Cites] Hum Pathol. 1985 Jul;16(7):746-51 [3891579.001]
  • [Cites] Regul Pept. 1987 Jan;17(1):9-29 [2882565.001]
  • [Cites] Endocr Rev. 1988 Aug;9(3):357-73 [3145190.001]
  • [Cites] Am J Surg Pathol. 1997 Sep;21(9):1075-82 [9298884.001]
  • [Cites] Gastroenterol Clin North Am. 1989 Dec;18(4):671-93 [2575601.001]
  • [Cites] Endocr Pathol. 1995 Autumn;6(3):229-237 [12114744.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1986;408(5):475-89 [2869609.001]
  • [Cites] Yale J Biol Med. 1996 Jan-Feb;69(1):69-74 [9041691.001]
  • [Cites] Hum Pathol. 1979 May;10(3):350-3 [89070.001]
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12):1581-7 [17122515.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1980;388(1):51-67 [6258288.001]
  • [Cites] Neuroendocrinology. 2005;81(6):400-4 [16276118.001]
  • [Cites] Gastroenterology. 1968 Dec;55(6):677-86 [4302500.001]
  • [Cites] Br J Surg. 1993 Apr;80(4):502-4 [8495322.001]
  • [Cites] Virchows Arch. 2007 Aug;451 Suppl 1:S39-46 [17684763.001]
  • [Cites] Am J Pathol. 1984 Nov;117(2):167-70 [6093542.001]
  • [Cites] Surg Today. 1997;27(2):112-9 [9017986.001]
  • [Cites] Ann Surg. 1979 Jun;189(6):677-82 [222222.001]
  • [Cites] Virchows Arch. 2004 Sep;445(3):248-54 [15517368.001]
  • [Cites] N Engl J Med. 1986 Jul 31;315(5):287-91 [3014338.001]
  • [Cites] J Clin Gastroenterol. 2001 Aug;33(2):154-6 [11468445.001]
  • [Cites] Am J Surg Pathol. 2004 Sep;28(9):1233-9 [15316325.001]
  • [Cites] Ann Surg. 1981 Dec;194(6):692-7 [7030236.001]
  • [Cites] N Engl J Med. 1999 Aug 26;341(9):635-44 [10460814.001]
  • [Cites] Ann Surg. 1989 Apr;209(4):396-404 [2930285.001]
  • [Cites] Am J Clin Pathol. 1989 Jan;91(1):52-6 [2462784.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1975;365(4):275-88 [46649.001]
  • [Cites] Br J Cancer. 2000 Oct;83(7):952-5 [10970700.001]
  • [Cites] Cancer. 2001 Oct 15;92(8):2204-10 [11596039.001]
  • [Cites] Mayo Clin Proc. 1974 Jan;49(1):44-51 [4149030.001]
  • [Cites] J Pediatr Surg. 2002 Jun;37(6):887-92 [12037756.001]
  • [Cites] Cancer. 1997 Apr 15;79(8):1476-81 [9118026.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1985;405(3):311-23 [2579503.001]
  • [Cites] Scand J Gastroenterol. 1980;15(2):129-35 [6247758.001]
  • [Cites] Cancer. 1971 Oct;28(4):990-8 [4106849.001]
  • [Cites] J Clin Oncol. 2004 Jul 1;22(13):2730-9 [15226341.001]
  • [Cites] Am J Surg Pathol. 2005 May;29(5):588-94 [15832081.001]
  • [Cites] Ann Surg. 1986 Oct;204(4):468-79 [3532971.001]
  • [Cites] Digestion. 1999 Sep-Oct;60(5):428-39 [10473967.001]
  • [Cites] Endocr Pathol. 2003 Winter;14(4):293-301 [14739487.001]
  • [Cites] Ann Surg. 1983 May;197(5):594-607 [6847279.001]
  • [Cites] Cancer. 1981 Nov 1;48(9):2029-37 [6271390.001]
  • [Cites] Hum Pathol. 1994 Feb;25(2):175-80 [8119718.001]
  • [Cites] Mayo Clin Proc. 1990 Nov;65(11):1399-407 [1700240.001]
  • [Cites] Dig Dis Sci. 1991 Jul;36(7):933-42 [2070707.001]
  • [Cites] J Exp Clin Cancer Res. 1998 Dec;17(4):379-88 [10089055.001]
  • [Cites] Cancer. 1989 Jun 15;63(12):2540-5 [2655873.001]
  • [Cites] Am J Gastroenterol. 1981 Aug;76(2):125-31 [6272569.001]
  • [Cites] J Clin Pathol. 2003 Dec;56(12):963-5 [14645360.001]
  • [Cites] J Pediatr Surg. 1985 Dec;20(6):734-6 [3003324.001]
  • [Cites] Am J Surg Pathol. 2006 May;30(5):560-74 [16699310.001]
  • [Cites] Am J Clin Pathol. 2003 Nov;120(5):706-11 [14608896.001]
  • [Cites] Cancer. 1979 Nov;44(5):1853-9 [227580.001]
  • [Cites] Am J Surg. 1985 Jun;149(6):775-9 [2409828.001]
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12):1531-6 [17122508.001]
  • [Cites] Cancer. 1983 Nov 15;52(10):1860-74 [6627205.001]
  • [Cites] Cancer. 2005 Apr 15;103(8):1587-95 [15742328.001]
  • [Cites] Am J Surg. 1984 Jan;147(1):25-31 [6691547.001]
  • [Cites] N Engl J Med. 1979 Aug 9;301(6):285-92 [377080.001]
  • [Cites] Gut. 2007 May;56(5):637-44 [17135306.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1717-51 [15887161.001]
  • [Cites] Semin Oncol. 2007 Feb;34(1):43-50 [17270665.001]
  • [Cites] Mol Endocrinol. 1989 Oct;3(10):1589-95 [2691879.001]
  • [Cites] Mayo Clin Proc. 1976 Jul;51(7):417-29 [180358.001]
  • [Cites] J Surg Oncol. 1991 Mar;46(3):174-7 [1849211.001]
  • [Cites] Am J Surg Pathol. 1977 Sep;1(3):207-16 [920868.001]
  • [Cites] Cancer. 1987 Feb 15;59(4):772-8 [3026608.001]
  • [Cites] World J Surg. 1993 Jul-Aug;17(4):481-8 [8103250.001]
  • [Cites] Cancer. 1994 Jun 15;73(12):2894-9 [8199985.001]
  • [Cites] Am J Surg Pathol. 1984 Aug;8(8):607-14 [6205601.001]
  • [Cites] Am J Surg. 1979 Jan;137(1):142-8 [215044.001]
  • [Cites] Mayo Clin Proc. 1991 Jul;66(7):711-9 [1677058.001]
  • [Cites] Am J Clin Pathol. 1991 Mar;95(3):315-21 [1847579.001]
  • [Cites] Cancer. 1984 Nov 15;54(10):2097-108 [6435852.001]
  • [Cites] Scand J Gastroenterol Suppl. 1979;53:79-91 [290036.001]
  • [Cites] Cancer. 1997 Mar 15;79(6):1086-93 [9070484.001]
  • [Cites] Cancer. 2003 Feb 15;97(4):934-59 [12569593.001]
  • [Cites] Am J Surg. 1983 Jul;146(1):124-32 [6869670.001]
  • [Cites] Semin Oncol. 1987 Sep;14(3):263-81 [2820062.001]
  • [Cites] Virchows Arch. 2000 Mar;436(3):217-23 [10782879.001]
  • [Cites] Am J Surg Pathol. 2005 Jul;29(7):969-75 [15958864.001]
  • [Cites] Dis Colon Rectum. 1972 Sep-Oct;15(5):383-91 [4561188.001]
  • [Cites] Digestion. 1995;56(6):455-62 [8536814.001]
  • [Cites] Ann Surg. 1992 Jan;215(1):8-18 [1531004.001]
  • [Cites] Virchows Arch. 2001 Dec;439(6):776-81 [11787850.001]
  • [Cites] Pathol Res Pract. 1992 Aug;188(6):751-6 [1437839.001]
  • [Cites] Chest. 1995 Jan;107(1):179-81 [7813272.001]
  • [Cites] Gut. 2002 Aug;51(2):184-90 [12117877.001]
  • [Cites] Ann Surg. 1955 Oct;142(4):709-23; discussion, 724-8 [13259432.001]
  • [Cites] J Clin Endocrinol Metab. 1983 Jun;56(6):1236-42 [6132927.001]
  • [Cites] Mayo Clin Proc. 1978 Jan;53(1):19-23 [625140.001]
  • [Cites] Am J Clin Pathol. 1986 Jan;85(1):13-20 [3000164.001]
  • [Cites] Cancer. 1975 Aug;36(2):560-9 [1157019.001]
  • [Cites] J Clin Pathol. 2001 Nov;54(11):880-2 [11684726.001]
  • [Cites] Am J Pathol. 1998 Jul;153(1):223-31 [9665483.001]
  • [Cites] Gastroenterology. 1985 Mar;88(3):798-803 [2981755.001]
  • [Cites] Am J Gastroenterol. 1986 Jan;81(1):33-7 [2867674.001]
  • [Cites] Am J Clin Pathol. 1987 Aug;88(2):153-61 [2887104.001]
  • [Cites] Arch Pathol Lab Med. 1990 Jul;114(7):700-4 [1694655.001]
  • [Cites] Pathol Res Pract. 1988 Apr;183(2):155-68 [2898775.001]
  • [Cites] Ann Surg. 1990 Jan;211(1):9-14 [2294850.001]
  • [Cites] Endocr Pathol. 1997 Winter;8(4):327-333 [12114794.001]
  • [Cites] Histopathology. 1992 Sep;21(3):215-23 [1356906.001]
  • [Cites] Gastroenterology. 1995 Jun;108(6):1637-49 [7768367.001]
  • [Cites] J Clin Pathol. 1993 Feb;46(2):183-5 [8459042.001]
  • [Cites] World J Gastroenterol. 2006 Sep 14;12(34):5440-6 [17006979.001]
  • [Cites] Am J Surg Pathol. 1986 May;10(5):348-57 [2422964.001]
  • [Cites] Am J Surg. 1980 Jul;140(1):119-25 [6249135.001]
  • [Cites] Dis Colon Rectum. 2005 Dec;48(12):2264-71 [16258711.001]
  • [Cites] Am J Surg Pathol. 1998 Feb;22(2):251-5 [9500228.001]
  • [Cites] Surgery. 1974 Apr;75(4):597-609 [4366135.001]
  • [Cites] Am J Surg Pathol. 2003 Dec;27(12):1551-8 [14657715.001]
  • [Cites] Virchows Arch. 2007 Oct;451(4):757-62 [17674042.001]
  • [Cites] Med Pediatr Oncol. 2002 Jan;38(1):65-6 [11835243.001]
  • [Cites] N Engl J Med. 1990 Mar 15;322(11):723-7 [1968616.001]
  • [Cites] Cancer. 1990 Jan 1;65(1):135-40 [2293859.001]
  • [Cites] Gastroenterology. 1993 Apr;104(4):994-1006 [7681798.001]
  • [Cites] Lancet. 1963 Feb 2;1(7275):238-9 [14000847.001]
  • [Cites] Diabetes. 1979 Oct;28(10):925-36 [383556.001]
  • [Cites] Cancer. 1993 Oct 15;72(8):2320-2 [8402445.001]
  • [Cites] Br J Surg. 1979 Jun;66(6):373-8 [223712.001]
  • [Cites] Ann Surg. 2004 Jul;240(1):117-22 [15213627.001]
  • [Cites] J Exp Clin Cancer Res. 1998 Jun;17(2):139-48 [9700573.001]
  • [Cites] Postgrad Med J. 1995 Aug;71(838):485-6 [7567757.001]
  • [Cites] Histopathology. 1986 Feb;10(2):119-33 [3007321.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):752-60 [11395552.001]
  • [Cites] Am J Surg Pathol. 2007 Nov;31(11):1677-82 [18059224.001]
  • [Cites] Virchows Arch. 2006 Nov;449(5):499-506 [17033797.001]
  • [Cites] Virchows Arch. 2007 Aug;451 Suppl 1:S29-38 [17684762.001]
  • [Cites] Gastroenterology. 1997 Sep;113(3):773-81 [9287968.001]
  • [Cites] J Natl Cancer Inst. 1997 Oct 1;89(19):1448-53 [9326914.001]
  • [Cites] J Clin Endocrinol Metab. 1981 Apr;52(4):820-2 [7204545.001]
  • [Cites] World J Surg. 1996 Feb;20(2):183-8 [8661815.001]
  • [Cites] Am J Clin Pathol. 1989 Jul;92(1):1-9 [2750701.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1981;392(3):263-9 [6115499.001]
  • (PMID = 17684761.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 176
  •  go-up   go-down


72. Koyuncu BO, Zeytinoğlu M, Unal T, Zeytinoğlu B: Myofibroma of the gingiva: report of a case. J Clin Pediatr Dent; 2010;34(3):253-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myofibroma of the gingiva: report of a case.
  • Myofibroma is a benign mesenchymal neoplasm composed of myofibroblasts which has been described with different synonyms since the first report in 1951.
  • Awareness and recognition of this benign tumor is important to establish the correct diagnosis and avoid morbidity of unnecessary aggressive therapy.
  • The tumor showed rapid increase in size and clinical features suggestive of malignancy.
  • However on histopathologic evaluation it was diagnosed as a benign neoplasm, and this diagnosis was supported by immunohistochemical markers.
  • [MeSH-major] Gingival Neoplasms / diagnosis. Myofibroma / diagnosis
  • [MeSH-minor] Actins / analysis. Adolescent. Desmin / analysis. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Immunohistochemistry. S100 Proteins / analysis. Vimentin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20578664.001).
  • [ISSN] 1053-4628
  • [Journal-full-title] The Journal of clinical pediatric dentistry
  • [ISO-abbreviation] J Clin Pediatr Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Desmin; 0 / S100 Proteins; 0 / Vimentin
  •  go-up   go-down


73. Roussel A, Thomassin-Naggara I, Darai E, Marsault C, Bazot M: [Value of diffusion-weighted imaging in the evaluation of adnexal tumors]. J Radiol; 2009 May;90(5 Pt 1):589-96

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Value of diffusion-weighted imaging in the evaluation of adnexal tumors].
  • [Transliterated title] Evaluation de la séquence de diffusion pour l'étude des tumeurs annexielles.
  • PURPOSE: To determine the value of diffusion-weighted imaging (DWI) in the evaluation of adnexal tumors, especially to distinguish between malignant and benign tumors.
  • Fifty-four patients with pelvic tumors (32 malignant and 22 benign) were referred for MRI of the pelvis.
  • The signal of solid and cystic tumor components was evaluated on T2W and b=1000 DWI, and ADC values were obtained.
  • RESULTS: T2W hypointensity or absence of hyperintense signal on b=1000 DWI sequences was suggestive of a benign tumor.
  • ADC values did not appear to discriminate between malignant and benign tumors.
  • Also, the signal intensity of cystic tumor components on DWI sequences was not helpful to distinguish between malignant and benign tumor.
  • CONCLUSION: The evaluation of solid tumor components on DWI appears to be helpful for adnexal tumor characterization.
  • [MeSH-major] Adnexal Diseases / diagnosis. Diffusion Magnetic Resonance Imaging / methods. Genital Neoplasms, Female / diagnosis. Image Enhancement. Image Processing, Computer-Assisted
  • [MeSH-minor] Adnexa Uteri / pathology. Adnexa Uteri / surgery. Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Middle Aged. Sensitivity and Specificity. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19503047.001).
  • [ISSN] 0221-0363
  • [Journal-full-title] Journal de radiologie
  • [ISO-abbreviation] J Radiol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


74. Hobson ML, Johari AS, Woon W, Haghighi KS: Mesenteric panniculitis causing ischemic bowel: a case report. Int Surg; 2008 Jul-Aug;93(4):238-40
Genetic Alliance. consumer health - Panniculitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This is the first publication of a rare benign tumor; mesenteric panniculitis causing acute on chronic ischemic bowel injury.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19731860.001).
  • [ISSN] 0020-8868
  • [Journal-full-title] International surgery
  • [ISO-abbreviation] Int Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


75. Situm M, Bolanca Z, Buljan M, Tomas D, Ivancić M: Nevus Spitz--everlasting diagnostic difficulties--the review. Coll Antropol; 2008 Oct;32 Suppl 2:171-6
Genetic Alliance. consumer health - Spitz nevus.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 1910, Darier and Civatte described in details an unusual melanocytic tumor characterized by rapid growth on the nose of a young child.
  • They could not state whether the tumor was benign or malignant.
  • Later, the study was revised and it was concluded that juvenile melanoma was a benign tumor and can affect adults.
  • Nowadays, there is still a lack of consensus about histopathology and also a terminology of the tumors that are neither typical nevus Spitz, neither malignant melanoma.
  • At the present, the final diagnosis remains pathohistological, with important emphasis given to clinical impression.
  • Barnhill recommends that all Spitz tumors are completely excised.
  • Atypical tumors should be excised with wider margins up to 1 cm.
  • [MeSH-minor] Diagnosis, Differential. Humans. Melanoma / pathology. Nevus / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Nevus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19140279.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Croatia
  • [Number-of-references] 28
  •  go-up   go-down


76. Vo QT, Wolf JA, Turner JW, Murkis M, Saw D, Shemen LJ: Solitary fibrous tumor of the parapharyngeal space. Ear Nose Throat J; 2007 Aug;86(8):502-5
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor of the parapharyngeal space.
  • Solitary fibrous tumors are benign neoplasms of mesenchymal origin.
  • We report a case of solitary fibrous tumor of the parapharyngeal space.
  • Microscopically, the tumor contained spindle cells with areas of marked hypercellularity without a definitepattern.
  • Consistent with a benign lesion, there were few mitoses and no necrosis.
  • The tumor cells stained strongly positive for CD34 and vimentin.
  • At the 2-year follow-up, the patient was well and free of local and/or distant disease.
  • [MeSH-major] Hemangiopericytoma / pathology. Hemangiopericytoma / surgery. Neoplasms, Fibrous Tissue / pathology. Neoplasms, Fibrous Tissue / surgery. Otorhinolaryngologic Surgical Procedures / methods. Pharyngeal Neoplasms / pathology. Pharyngeal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17915675.001).
  • [ISSN] 0145-5613
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. Wang X, Yu FL, Wu ZS, Chen MJ: [Clinical application of video-assisted thoracoscopic surgery]. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr;31(2):284-7
MedlinePlus Health Information. consumer health - Lung Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 17 thoracic diseases such as emphysema, bullectomy for spontaneous pneumothorax, massive bullae, benign tumor of mediastinum, cyst of mediastinum, pulmonary benign tumors, hydropericardium, malignant pleural fluid, etc.
  • A supplementary incision was needed in 10 cases: Six were due to the adhesion of full pleural cavity and 4 were found with the malignant tumor during the operation.
  • CONCLUSION: VATS is an alternative approach that provides a safe, less invasive, and effective operation for treating spontaneous pneumothorax, benign tumor of mediastinum, cyst of mediastinum, pulmonary benign tumors, pericardial perfusion, and acute chest trauma patients.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Emphysema / surgery. Female. Hemopneumothorax / surgery. Humans. Lung Neoplasms / surgery. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16706135.001).
  • [ISSN] 1672-7347
  • [Journal-full-title] Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
  • [ISO-abbreviation] Zhong Nan Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


78. Wu YH, Wan JH, Qi YF, Xu ZG, Tang PZ, Guo J: [Cooperation management by head and neck surgery and neurosurgery for skull base tumors]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun;44(6):475-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cooperation management by head and neck surgery and neurosurgery for skull base tumors].
  • OBJECTIVE: To present the experience and advantage of cooperation management by head and neck surgery and neurosurgery for communicating skull base tumors.
  • METHODS: A review of 54 communicating skull base tumors (benign tumor 21, malignant tumor 33) cooperation resection by head and neck surgery and neurosurgery from July 2005 to July 2008 in the Cancer Hospital of Chinese Academy of Medical Sciences was presented.
  • The tumor originated in the anterior skull base in 19 cases, originated in the lateral skull base in 12, in the central skull base in 17, and in the posterior skull base in 6.
  • Total resection of tumor was achieved in 45 cases, and subtotal resection was achieved in 9.
  • All cases except 3 were followed up with a period of 8 to 43 months (median, 19.1 months for benign tumor and 21.0 months for malignant tumor).
  • Three patients with malignant tumor were lost.
  • Twelve cases of malignant tumor and one case of benign tumor recurred postoperatively.
  • Nine patients with malignant tumor had died (one of these died from heart trouble).
  • Three-year disease-free survival rates and overall survival rates of malignant tumor were 52.7% and 53.0%, respectively.
  • CONCLUSIONS: It suggested that a special operative team constituted of head and neck surgeon and neurosurgeon may improve the outcome of the difficult skull base tumors.
  • [MeSH-major] Neurosurgical Procedures / methods. Otorhinolaryngologic Surgical Procedures / methods. Skull Base Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19954018.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


79. Burel-Vandenbos F, Cardot-Leccia N, Effi B, Varini JP, Saint-Paul MC, Michiels JF: [An unusual tumor of the adrenal gland]. Ann Pathol; 2005 Oct;25(5):386-8
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [An unusual tumor of the adrenal gland].
  • [Transliterated title] Une tumeur inhabituelle de la surrénale.
  • Adenomatoid tumors are benign mesothelial tumors that usually affect the genital tract.
  • We report the case of a 65-year-old man with an adenomatoid tumor of the adrenal gland.
  • This uncommon location and its histological heterogeneity can lead to a mistaken diagnosis of malignant tumor.
  • Positive cells with mesothelial markers in immunohistochemistry improve diagnosis.
  • The proper identification of this benign tumor in the adrenal gland and the knowledge of its differential diagnosis deserve attention to avoid invasive treatment.
  • [MeSH-major] Adenomatoid Tumor / pathology. Adrenal Gland Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adrenalectomy. Aged. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Lymphangioma / diagnosis. Male. Neoplasm Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16498291.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


80. Wang K, Wang T, Fu F, Ji ZY, Liu RG, Liao QM, Dong XZ: Electrical impedance scanning in breast tumor imaging: correlation with the growth pattern of lesion. Chin Med J (Engl); 2009 Jul 5;122(13):1501-6
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Electrical impedance scanning in breast tumor imaging: correlation with the growth pattern of lesion.
  • METHODS: The impedance character of 40 malignant tumors, 34 benign tumors and some normal breast tissue from 69 patients undergoing breast surgery was examined by EIS in vivo measurement and mammography screening, with a series of frequencies set between 100 Hz - 100 kHz in the ex vivo spectroscopy measurement.
  • RESULTS: Of the 39 patients with 40 malignant tumors, 24 showed bright spots, 11 showed dark areas in EIS and 5 showed no specific image.
  • Of the 30 patients with 34 benign tumors there were almost no specific abnormality shown in the EIS results.
  • Primary ex vivo spectroscopy experiments showed that the resistivity of various breast tissue take the following pattern: adipose tissue > cancerous tissue > mammary gland and benign tumor tissue.
  • The impedivity of benign tumor is lower, and is at the same level with that of the mammary glandular tissue.
  • [MeSH-major] Breast Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19719937.001).
  • [ISSN] 0366-6999
  • [Journal-full-title] Chinese medical journal
  • [ISO-abbreviation] Chin. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


81. Pino Rivero V, Trinidad Ruiz G, Pardo Romero G, González Palomino A, Pantoja Hernández CG, Marqués Rebollo L, Blasco Heulva A: [Cervical giant lipoma. Clinical report of a case and differential diagnosis]. An Otorrinolaringol Ibero Am; 2005;32(4):345-51
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cervical giant lipoma. Clinical report of a case and differential diagnosis].
  • [Transliterated title] Lipoma gigante cervical. Presentación clínica de un caso y diagnóstico diferencial.
  • Lipomas represent one of the most common benign tumours in any location.
  • However, the giant variants are relatively uncommon and cause diagnostic problems with other neoplasm benign and malign.
  • We are reporting the case of a 69 years-old male who presented a neck mass which size was more than 12 cm of diameter and corresponded to lipoma after its removal and anatomopathologic exam.
  • [MeSH-major] Head and Neck Neoplasms / radiography. Lipoma / radiography
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Male. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16156364.001).
  • [ISSN] 0303-8874
  • [Journal-full-title] Anales otorrinolaringológicos ibero-americanos
  • [ISO-abbreviation] An Otorrinolaringol Ibero Am
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


82. Terauchi F, Onodera T, Nagashima T, Kobayashi Y, Moritake T, Oharaseki T, Ogura H: Sclerosing stromal tumor of the ovary with elevated CA125. J Obstet Gynaecol Res; 2005 Oct;31(5):432-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sclerosing stromal tumor of the ovary with elevated CA125.
  • The case is reported herein of an 18-year-old woman who developed sclerosing stromal tumor of the ovary.
  • Although she was suspected to have a malignant tumor due to magnetic resonance imaging findings and an abnormal blood CA125 value, the tumor was benign.
  • She had an uneventful postoperative course, with no postoperative recurrence of the tumor.
  • [MeSH-major] CA-125 Antigen / blood. Ovarian Neoplasms / blood. Ovarian Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16176513.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / CA-125 Antigen
  •  go-up   go-down


83. Ducic Y, Oxford L, Pontius AT: Transoral approach to the superomedial parapharyngeal space. Otolaryngol Head Neck Surg; 2006 Mar;134(3):466-70
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To present our early experience with the transoral approach to the superomedial parapharyngeal space (PPS) and describe our technique for removal of these neoplasms.
  • METHODS: Eight patients with various neoplasms of the superomedial PPS were retrospectively reviewed for type of neoplasm, size, success with the transoral approach, need for conversion to another approach, length of hospitalization, and complications.
  • RESULTS: The transoral approach described herein safely allowed for en bloc resection of benign neoplasms with intraoperative control and exposure of the internal carotid artery.
  • Mean tumor size was 3.3 cm (range, 1.5 to 7 cm).
  • This technique is indicated for neoplasms with benign appearance on preoperative imaging or fine needle aspiration.
  • [MeSH-major] Mouth / surgery. Pharyngeal Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Biopsy, Needle. Carotid Artery, Internal / pathology. Child. Female. Follow-Up Studies. Humans. Intraoperative Care. Length of Stay. Male. Middle Aged. Neoplasm Invasiveness. Neurilemmoma / pathology. Neurilemmoma / surgery. Postoperative Complications. Retrospective Studies. Teratoma / pathology. Teratoma / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16500446.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Yamaguchi M, Yagi K, Ikeya E, Fujimura T, Taguchi J, Shibuya M, Inamura S, Kanabuchi K: A case report of papillary fibroelastoma attached to chorda tendineae of mitral valve. Tokai J Exp Clin Med; 2006 Jul;31(2):56-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A bulbar mass attached to mitral valve anterior leaflet was discovered in an echocardiography within detailed examination of ischemic heart disease accidentally.
  • We diagnosed him as ischemic heart disease and doubt of heart tumor.
  • We dissected the tumor together with one chorda tendineae of mitral valve, and a performed aorta - coronary bypass surgery.
  • We diagnosed the tumor as papillary fibroelastoma by pathological diagnosis.
  • Papillary fibroelastoma is extremely rare with 7-9% of benign tumor of heart primary.
  • The tumor is benign, but there is a problem to cause embolism.
  • Therefore, when we discovered papillary fibroelastoma, surgical resection of the tumor is the first-line therapy.
  • Papillary fibroelastoma is benign tumor, but the pathological characteristic is still unidentified.
  • [MeSH-major] Chordae Tendineae / pathology. Fibroma / pathology. Heart Neoplasms / pathology. Mitral Valve / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21302223.001).
  • [ISSN] 2185-2243
  • [Journal-full-title] The Tokai journal of experimental and clinical medicine
  • [ISO-abbreviation] Tokai J. Exp. Clin. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


85. Cosso R, Nuzzo V, Zuccoli A, Brandi ML, Falchetti A: Giant cell tumor in a case of Paget's disease of bone: an aggressive benign tumor exhibiting a quick response to an innovative therapeutic agent. Clin Cases Miner Bone Metab; 2010 May;7(2):145-52

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant cell tumor in a case of Paget's disease of bone: an aggressive benign tumor exhibiting a quick response to an innovative therapeutic agent.
  • Giant cell tumor of bone, also called osteoclastoma, is a rare skeletal complication of Paget's disease of bone.
  • We will focus on either a review on this rare bone tumor, including some genetic aspects, or the current established therapies.
  • Finally, we will describe the therapeutic outcomes of this unique complication of Paget's disease of bone as a rapid response to an innovative therapeutic agent.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22460021.001).
  • [ISSN] 1971-3266
  • [Journal-full-title] Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases
  • [ISO-abbreviation] Clin Cases Miner Bone Metab
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC3004463
  •  go-up   go-down


86. Taskinen S, Fagerholm R, Aronniemi J, Rintala R, Taskinen M: Testicular tumors in children and adolescents. J Pediatr Urol; 2008 Apr;4(2):134-7
MedlinePlus Health Information. consumer health - Testicular Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Testicular tumors in children and adolescents.
  • OBJECTIVE: To analyze the spectrum of testicular tumors in children in an unselected population-based series, as well as the results of testis-preserving surgery.
  • PATIENTS AND METHODS: Our hospital database was analyzed for operations for testicular tumors from 1981 to 2006.
  • RESULTS: Thirty-four patients were operated on because of testicular tumors.
  • In 23 (68%) the tumor was benign: benign teratoma (16), Leydig-cell tumor (2), epidermoid cyst (2), Sertoli-cell tumor (1), cystic dysplasia (1), intratesticular focal fibrosis (1).
  • Eleven patients (32%) had a malignant tumor: yolk-sac tumor (6), embryonal carcinoma (5).
  • Twenty out of the 26 (77%) prepubertal boys had a benign tumor in contrast to only three of the eight (38%) adolescent males (P=0.079).
  • In eight, the tumor was curatively excised and remaining testis preserved.
  • Two patients with benign teratoma had a recurrence due to incomplete primary resection.
  • In one patient who underwent orchiectomy for benign teratoma, two metachronous teratomas were detected in the contralateral testis 6 years after primary surgery.
  • CONCLUSIONS: In children, most testicular tumors are benign, especially before puberty.
  • If testis-preserving surgery is contemplated, complete excision of the tumor should be ascertained.
  • The possibility of metachronous bilateral tumors should be considered in the follow up of testicular teratomas.
  • [MeSH-major] Teratoma / epidemiology. Teratoma / surgery. Testicular Neoplasms / epidemiology. Testicular Neoplasms / surgery
  • [MeSH-minor] Adolescent. Carcinoma, Embryonal / epidemiology. Carcinoma, Embryonal / surgery. Child. Databases, Factual. Endodermal Sinus Tumor / epidemiology. Endodermal Sinus Tumor / surgery. Epidermal Cyst / epidemiology. Epidermal Cyst / surgery. Follow-Up Studies. Humans. Incidence. Leydig Cell Tumor / epidemiology. Leydig Cell Tumor / surgery. Male. Retrospective Studies. Sertoli Cell Tumor / epidemiology. Sertoli Cell Tumor / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18631909.001).
  • [ISSN] 1873-4898
  • [Journal-full-title] Journal of pediatric urology
  • [ISO-abbreviation] J Pediatr Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


87. Harikumar R, Simikumar, Aravindan SK, Thomas V: Abrikosoff's tumor of the esophagus: case report and review of literature. Trop Gastroenterol; 2006 Jan-Mar;27(1):52-3
MedlinePlus Health Information. consumer health - Esophageal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abrikosoff's tumor of the esophagus: case report and review of literature.
  • Abrikosoff's tumor or granular cell tumor is a neoplasm of neural origin, usually located in the head and neck region.
  • A majority of these neoplasms are benign.
  • Only 4-6% of granular cell tumors are located in the gastrointestinal tract.
  • It is extremely unusual for these tumors to be located in the esophagus.
  • [MeSH-major] Esophageal Neoplasms / pathology. Granular Cell Tumor / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16910065.001).
  • [ISSN] 0250-636X
  • [Journal-full-title] Tropical gastroenterology : official journal of the Digestive Diseases Foundation
  • [ISO-abbreviation] Trop Gastroenterol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Number-of-references] 13
  •  go-up   go-down


88. Coulon A, Milin S, Laban E, Debiais C, Jamet C, Goujon JM: [Pathologic characteristics of the most frequent peripheral nerve tumors]. Neurochirurgie; 2009 Oct;55(4-5):454-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pathologic characteristics of the most frequent peripheral nerve tumors].
  • [Transliterated title] Aspects histopathologiques des principales tumeurs des nerfs périphériques.
  • Benign tumors of the peripheral nerves come from ectodermic tissues.
  • The benign tumor structures account for the fact that they can be removed with or without preserving the concerned nerve.
  • Malignant tumors (malignant peripheral sheath tumors) come from degeneration of neurofibromas in two out of three cases and have a poor prognosis.
  • [MeSH-major] Nerve Sheath Neoplasms / pathology. Neurilemmoma / pathology. Neurofibroma / pathology. Peripheral Nervous System Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19744677.001).
  • [ISSN] 0028-3770
  • [Journal-full-title] Neuro-Chirurgie
  • [ISO-abbreviation] Neurochirurgie
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 13
  •  go-up   go-down


89. Al Harthi B, Riaz MM, Al Khalaf AH, Al Zoum M, Al Shakweer W: Adrenal myelolipoma a rare benign tumour managed laparoscopically: Report of two cases. J Minim Access Surg; 2009 Oct;5(4):118-20

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal myelolipoma a rare benign tumour managed laparoscopically: Report of two cases.
  • Adrenal Myelolipoma is a rare benign neoplasm composed of mature adipose tissue and a variable amount of haemopoietic elements.
  • Two cases of myelolipoma are presented here, where the tumours were hormonally inactive, but presented with abdominal symptoms and were managed by laparoscopic adrenalectomy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1998 Jul;208(1):87-95 [9646797.001]
  • [Cites] J Urol. 1997 Apr;157(4):1213-6 [9120904.001]
  • [Cites] Surgery. 1973 May;73(5):665-70 [4697085.001]
  • [Cites] J Urol. 1992 Apr;147(4):1089-90 [1552592.001]
  • [Cites] Ir Med J. 2001 Sep;94(8):231-3 [11758622.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2003 Apr;13(2):106-10 [12709616.001]
  • [Cites] J Urol. 1992 Jun;147(6):1478-81 [1593668.001]
  • (PMID = 20407573.001).
  • [ISSN] 1998-3921
  • [Journal-full-title] Journal of minimal access surgery
  • [ISO-abbreviation] J Minim Access Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2843128
  • [Keywords] NOTNLM ; Angiomyelolipoma / laparoscopic adrenalectomy / myelolipoma
  •  go-up   go-down


90. Smith MA: Multiple synchronous atrial lipomas. Cardiovasc Pathol; 2007 May-Jun;16(3):187-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The incidence of primary tumors of the heart is low.
  • Three quarters of cardiac neoplasms are benign.
  • Cardiac lipomas are a mostly asymptomatic benign tumor that makes up less than 10% of primary heart tumors.
  • [MeSH-major] Heart Neoplasms / pathology. Lipoma / pathology. Neoplasms, Multiple Primary / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17502250.001).
  • [ISSN] 1054-8807
  • [Journal-full-title] Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
  • [ISO-abbreviation] Cardiovasc. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Ahuja JR, Amonkar GP, Deshpande J: Papillary fibroelastoma of the heart. Indian J Pathol Microbiol; 2008 Oct-Dec;51(4):559-60
MedlinePlus Health Information. consumer health - Heart Valve Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary intra-cardiac tumors are rare.
  • Most of them are benign.
  • Of the benign tumors, myxomas are the most common.
  • PFE is a relatively rare benign tumor of the heart.
  • It is important to be aware of this entity because even though it is benign it may present with life-threatening complications, which are well documented in literature.
  • Surgery is the treatment of choice for these tumors.
  • We present the case of a 30-year-old male in whom PFE was an incidental finding.
  • [MeSH-major] Aortic Valve / pathology. Fibroma / pathology. Heart Neoplasms / pathology. Heart Valve Diseases / pathology. Papillary Muscles / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19008597.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


92. Rosner IL, Ravindranath L, Furusato B, Chen Y, Gao C, Cullen J, Sesterhenn IA, McLeod DG, Srivastava S, Petrovics G: Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy. Urology; 2007 Dec;70(6):1225-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
  • Because AR mutations or amplification are rare in early stage CaP, we hypothesized that altered AR expression in prostate tumor cells may provide a prognostic indicator of disease progression.
  • METHODS: RNA from laser capture microdissected (LCM) tumor and benign epithelial cells from radical prostatectomy specimens of 115 hormone-naive patients were studied.
  • A ratio of the expression of AR gene, normalized to GAPDH gene expression in the same specimens, was compared in tumor and benign epithelial cells (tumor-to-benign ratio) and correlated with clinicopathologic features.
  • RESULTS: Paired t test analysis revealed a 62% lower AR expression in tumor tissue compared with benign tissue (P = 0.0005).
  • However, multivariate Cox proportional hazards regression analysis of time to PSA recurrence revealed that higher tumor cell associated AR expression (continuous, log-transformed), significantly increases odds of prostate-specific antigen (PSA) recurrence (P = 0.0139) when controlling for age at surgery, race, time from diagnosis to surgery, risk stratification, pathologic T stage, Gleason sum, and margin status.
  • [MeSH-major] Prostate / metabolism. Prostatectomy. Prostatic Neoplasms / metabolism. Receptors, Androgen / metabolism
  • [MeSH-minor] Adult. Disease Progression. Gene Expression. Humans. Male. Prognosis. Prostate-Specific Antigen / blood. RNA, Messenger / analysis. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction


93. Lu YC, Fan WJ, Shen JX, Xiao P: [CT features of parotid tumors: an analysis of 133 cases]. Ai Zheng; 2007 Nov;26(11):1263-7
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [CT features of parotid tumors: an analysis of 133 cases].
  • BACKGROUND & OBJECTIVE: Most parotid tumors grow slowly.
  • This study was to analyze the CT features of parotid tumors.
  • METHODS: CT images of 133 patients with 157 lesions of parotid tumors, confirmed by histopathology, were reviewed.
  • RESULTS: Among the 157 lesions, 110 (70.1%) were benign tumors, 18 (11.5%) were borderline tumors, and 29 (18.5%) were malignant tumors; 80 (72.7%) benign lesions and 14 (77.8%) borderline lesions located in the superficial lobe, whereas 7 (24.1%) malignant lesions located in the deep lobe and 10 (34.5%) in both the superficial lobe and the deep lobe; 99 (90.0%) benign lesions had sharp margins, 8 (44.4%) borderline lesions had sharp margins and 10 (55.6%) had partly unsharp margins, 10 (34.5%) malignant lesions had partly unsharp margins and 11 (37.9%) had unsharp margins.
  • Most benign lesions were round (68/110, 61.8%) or oval (23/110, 20.9%), while malignant lesions were often irregular (14/29, 48.3%).
  • Eleven lesions, including 2 borderline tumors and 9 malignant tumors, involved the adjacent subcutaneous fat.
  • No benign tumor involved adjacent structures.
  • CONCLUSION: On CT images, a parotid tumor located in the superficial lobe, with a round or oval contour and sharp margin, is more likely to be a benign tumor; otherwise, it might be a malignant tumor.
  • [MeSH-major] Adenolymphoma / radiography. Carcinoma, Mucoepidermoid / radiography. Parotid Neoplasms / radiography. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adenoma, Pleomorphic / pathology. Adenoma, Pleomorphic / radiography. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Acinar Cell / pathology. Carcinoma, Acinar Cell / radiography. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / radiography. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Parotid Gland / pathology. Parotid Gland / radiography. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17991330.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


94. Casanova Espinosa A, Cisneros Serrano C, Girón Moreno RM, Olivera MJ, Moreno Balsalobre R, Zamora García E: [Pleural empyema associated with endobronchial lipoma]. Arch Bronconeumol; 2005 Mar;41(3):172-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bronchial benign tumors comprise fewer than 4% of pulmonary neoplasms.
  • Endobronchial lipoma is an extremely rare benign neoplasm accounting for only 0.1% to 0.5% of all lung tumors.
  • Clinical symptoms of lipoma depend on the location of the tumor, the severity of bronchial obstruction, and the functional and anatomical effects on the parenchyma distal to the obstruction.
  • Computed axial tomography usually reveals the adipose composition of the lipomatous tumor.
  • [MeSH-major] Bronchial Neoplasms / complications. Empyema, Pleural / etiology. Lipoma / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15766470.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


95. Torres-Domingo S, Bagan JV, Jiménez Y, Poveda R, Murillo J, Díaz JM, Sanchis JM, Gavaldá C, Carbonell E: Benign tumors of the oral mucosa: a study of 300 patients. Med Oral Patol Oral Cir Bucal; 2008 Mar;13(3):E161-6
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign tumors of the oral mucosa: a study of 300 patients.
  • OBJECTIVES: To analyze the frequency and type of the most common benign tumors of the oral mucosa found at the Hospital Stomatology Service, and to study the clinical characteristics and possible etiological factors.
  • MATERIAL AND METHODS: This is a retrospective study of 300 patients with histologically diagnosed benign tumors of the oral mucosa.
  • Data was compiled for each case, documenting information relating to age, gender, medication, habits (smoking, oral hygiene), anamnesis (reason for consultation, symptomatology, evolution), and the characteristics of the lesion (site, color, size, surface, consistency, and base).
  • RESULTS: Of all the tumors studied, 53% were histologically diagnosed as fibroma.
  • In the study of prevalence of benign tumors of the oral mucosa, no differences were found for age; however there were differences according to gender, finding a greater prevalence of fibromas, pyogenic granulomas, and giant cell granulomas in women, at a ratio of 2:1.
  • The group of tumors studied showed a significantly asymptomatic behaviour, and self-limiting and slow growth.
  • CONCLUSIONS: Following the study of 300 patients histologically diagnosed with benign tumor of the oral mucosa, we can state that with regard to prevalence, we found significant differences with respect to gender, being more frequent in women.
  • The fibroma is the most frequent benign tumor of the oral cavity.
  • [MeSH-major] Mouth Mucosa. Mouth Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18305435.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


96. Jidveianu NH, Puscasiu L, Vonica OC: Newborn's giant sacrococcigeal teratoma. Chirurgia (Bucur); 2010 May-Jun;105(3):423-5
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A sacrococcigeal tumor was detect at ultrasound maternal exam in 25TH week of pregnancy.
  • The newborn present a tumor with 12 cm diameter, situated in sacrococcigeal region, with a large base of implantation and with posteroinferior growth.
  • This tumor produced a dislocation of the rectum and a perineal area.
  • We removed a large tumor (600 gr) with the coccys bone and we obtained a good repair of anatomy of the region, without postoperatory functional troubles.
  • The histopatologic exam confirmed that the tumor was benign.
  • [MeSH-major] Coccyx. Skin Neoplasms / pathology. Skin Neoplasms / ultrasonography. Teratoma / pathology. Teratoma / ultrasonography. Ultrasonography, Prenatal

  • Genetic Alliance. consumer health - Teratoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20726314.001).
  • [ISSN] 1221-9118
  • [Journal-full-title] Chirurgia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Chirurgia (Bucur)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


97. Ferri E, Iaderosa GA, Armato E: Atypical fibroxanthoma of the external ear in a cardiac transplant recipient: case report and the causal role of the immunosuppressive therapy. Auris Nasus Larynx; 2008 Jun;35(2):260-3
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Atypical fibroxanthoma (AF) is an unusual cutaneous fibrohistiocytic tumour that is most commonly found in ENT sun-exposed areas of elderly males.
  • Cardiac transplant patients have an increased incidence of multiple cutaneous neoplasms, but the AF is uncommon.
  • Although this neoplasm is benign, it may mimic spindle cell carcinoma, squamous cell carcinoma, melanoma and soft tissue sarcoma on histologic examination.
  • Immunohistochemical stains for cytokeratin, alpha-1-antichymotrypsin, S100 protein and vimentin may be helpful in differential diagnosis.
  • We present a case of a cardiac transplant recipient who developed, after multiple cutaneous squamous tumours, an AF of external ear following the prolonged immunosuppressive treatment with cyclosporin.
  • [MeSH-major] Ear Neoplasms / pathology. Ear, External. Heart Transplantation. Histiocytoma, Benign Fibrous / pathology
  • [MeSH-minor] Aged. Cyclosporins. Diagnosis, Differential. Humans. Immunosuppressive Agents / adverse effects. Male. Postoperative Complications

  • MedlinePlus Health Information. consumer health - Heart Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17804184.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Cyclosporins; 0 / Immunosuppressive Agents
  •  go-up   go-down


98. Tansel T, Toker A, Yilmazbayhan D, Gullluoglu M, Dayioglu E: Primary endobronchial schwannoma. J Pediatr Surg; 2010 Nov;45(11):2241-3
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary intrabronchial neurilemmas, also called schwannomas, are extremely rare tumors that originate from Schwann cells.
  • The diagnosis was made by bronchofiberscopic biopsy.
  • Although the tumor was benign, the patient was subjected to left pneumonectomy because of destruction of the pulmonary parenchyma distal to the obstruction.
  • The diagnosis of intrabronchial schwannoma was supported pathologically with characteristic findings on Antoni A and Antoni B areas.
  • [MeSH-major] Bronchial Neoplasms / diagnosis. Neurilemmoma / diagnosis. Pneumonectomy / methods
  • [MeSH-minor] Biopsy. Bronchoscopy. Child. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Radiography, Thoracic. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 21034952.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Josephson GD, Patel SA, Duckworth L, Kress M, Goldstein J: Neurilemmoma presenting as a midline nasal mass in a pediatric patient. Ear Nose Throat J; 2010 May;89(5):221-3
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a case of a neurilemmoma presenting as a midline nasal mass in a 13-year-old girl.
  • To the best of our knowledge, this is the first report of a nasal neurilemmoma in a pediatric patient.
  • Although this neoplasm is benign in nature, surgical resection is warranted to prevent recurrence, and it is the sole means of treatment.
  • We discuss the diagnosis and management of neurilemmomas and urge physicians not to exclude nasal neurilemmoma from the differential diagnosis in a pediatric patient who presents with a nasal mass.
  • [MeSH-major] Nasal Cavity / pathology. Neurilemmoma / pathology. Nose Neoplasms / pathology
  • [MeSH-minor] Adolescent. Diagnosis, Differential. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20461682.001).
  • [ISSN] 1942-7522
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


100. Sydor A, Sulowicz W, Stompór T, Plezia B, Wrona A, Okon K: Two consecutive cases of renal oncocytomatosis in a single-center experience. Clin Nephrol; 2009 Apr;71(4):433-40
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Renal oncocytoma is a rare finding and represents the small percentage of all kidney tumors.
  • This kind of tumor is benign and diagnosed accidentally (on autopsy or during nephrectomy performed for other reasons).
  • On rare occasions, truly multiple tumors are seen, affecting the entire renal parenchyma; this condition is called oncocytosis or oncocytomatosis.
  • [MeSH-major] Adenoma, Oxyphilic / diagnosis. Kidney Neoplasms / diagnosis. Neoplasms, Multiple Primary / diagnosis
  • [MeSH-minor] Aged. Aged, 80 and over. Comorbidity. Diagnosis, Differential. Fatal Outcome. Female. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19356377.001).
  • [ISSN] 0301-0430
  • [Journal-full-title] Clinical nephrology
  • [ISO-abbreviation] Clin. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down






Advertisement